id	sid	tid	token	lemma	pos
ecj-12574	1	1	hrev_master	hrev_master	NOUN
ecj-12574	1	2	abstract	abstract	ADJ
ecj-12574	1	3	citalopram	citalopram	PROPN
ecj-12574	1	4	intoxications	intoxication	NOUN
ecj-12574	1	5	can	can	AUX
ecj-12574	1	6	lead	lead	VERB
ecj-12574	1	7	to	to	PART
ecj-12574	1	8	serotonin	serotonin	VERB
ecj-12574	1	9	syndrome	syndrome	NOUN
ecj-12574	1	10	(	(	PUNCT
ecj-12574	1	11	ss	ss	NOUN
ecj-12574	1	12	)	)	PUNCT
ecj-12574	1	13	development	development	NOUN
ecj-12574	1	14	,	,	PUNCT
ecj-12574	1	15	characterized	characterize	VERB
ecj-12574	1	16	by	by	ADP
ecj-12574	1	17	altered	alter	VERB
ecj-12574	1	18	mental	mental	ADJ
ecj-12574	1	19	status	status	NOUN
ecj-12574	1	20	,	,	PUNCT
ecj-12574	1	21	seizures	seizure	NOUN
ecj-12574	1	22	,	,	PUNCT
ecj-12574	1	23	autonomic	autonomic	ADJ
ecj-12574	1	24	instability	instability	NOUN
ecj-12574	1	25	,	,	PUNCT
ecj-12574	1	26	hyperthermia	hyperthermia	NOUN
ecj-12574	1	27	and	and	CCONJ
ecj-12574	1	28	extrapyramidal	extrapyramidal	ADJ
ecj-12574	1	29	signs	sign	NOUN
ecj-12574	1	30	.	.	PUNCT
ecj-12574	2	1	we	we	PRON
ecj-12574	2	2	review	review	VERB
ecj-12574	2	3	the	the	DET
ecj-12574	2	4	literature	literature	NOUN
ecj-12574	2	5	about	about	ADP
ecj-12574	2	6	pediatric	pediatric	ADJ
ecj-12574	2	7	acute	acute	PROPN
ecj-12574	2	8	citalopram	citalopram	PROPN
ecj-12574	2	9	intoxications	intoxication	NOUN
ecj-12574	2	10	,	,	PUNCT
ecj-12574	2	11	and	and	CCONJ
ecj-12574	2	12	we	we	PRON
ecj-12574	2	13	report	report	VERB
ecj-12574	2	14	a	a	DET
ecj-12574	2	15	case	case	NOUN
ecj-12574	2	16	of	of	ADP
ecj-12574	2	17	severe	severe	ADJ
ecj-12574	2	18	ss	ss	NOUN
ecj-12574	2	19	in	in	ADP
ecj-12574	2	20	an	an	DET
ecj-12574	2	21	infant	infant	NOUN
ecj-12574	2	22	associated	associate	VERB
ecj-12574	2	23	to	to	ADP
ecj-12574	2	24	posterior	posterior	ADJ
ecj-12574	2	25	reversible	reversible	ADJ
ecj-12574	2	26	encephalopathy	encephalopathy	ADJ
ecj-12574	2	27	syndrome	syndrome	NOUN
ecj-12574	2	28	(	(	PUNCT
ecj-12574	2	29	pres	pre	NOUN
ecj-12574	2	30	)	)	PUNCT
ecj-12574	2	31	treated	treat	VERB
ecj-12574	2	32	with	with	ADP
ecj-12574	2	33	cyproheptadine	cyproheptadine	NOUN
ecj-12574	2	34	as	as	ADP
ecj-12574	2	35	an	an	DET
ecj-12574	2	36	antidote	antidote	NOUN
ecj-12574	2	37	.	.	PUNCT
ecj-12574	3	1	an	an	DET
ecj-12574	3	2	adequate12	adequate12	NOUN
ecj-12574	3	3	-	-	PUNCT
ecj-12574	3	4	month	month	NOUN
ecj-12574	3	5	-	-	PUNCT
ecj-12574	3	6	old	old	ADJ
ecj-12574	3	7	girl	girl	NOUN
ecj-12574	3	8	displayed	display	VERB
ecj-12574	3	9	a	a	DET
ecj-12574	3	10	sudden	sudden	ADJ
ecj-12574	3	11	global	global	ADJ
ecj-12574	3	12	neurological	neurological	ADJ
ecj-12574	3	13	regression	regression	NOUN
ecj-12574	3	14	with	with	ADP
ecj-12574	3	15	hypotonia	hypotonia	NOUN
ecj-12574	3	16	,	,	PUNCT
ecj-12574	3	17	prolonged	prolong	VERB
ecj-12574	3	18	occipital	occipital	ADJ
ecj-12574	3	19	seizures	seizure	NOUN
ecj-12574	3	20	,	,	PUNCT
ecj-12574	3	21	right	right	ADJ
ecj-12574	3	22	hemiparesis	hemiparesis	NOUN
ecj-12574	3	23	and	and	CCONJ
ecj-12574	3	24	a	a	DET
ecj-12574	3	25	progressive	progressive	ADJ
ecj-12574	3	26	wakefulness	wakefulness	NOUN
ecj-12574	3	27	reduction	reduction	NOUN
ecj-12574	3	28	associated	associate	VERB
ecj-12574	3	29	with	with	ADP
ecj-12574	3	30	blindness	blindness	NOUN
ecj-12574	3	31	.	.	PUNCT
ecj-12574	4	1	plasmatic	plasmatic	ADJ
ecj-12574	4	2	concentration	concentration	NOUN
ecj-12574	4	3	of	of	ADP
ecj-12574	4	4	citalopram	citalopram	PROPN
ecj-12574	4	5	was	be	AUX
ecj-12574	4	6	equal	equal	ADJ
ecj-12574	4	7	to	to	ADP
ecj-12574	4	8	3225	3225	NUM
ecj-12574	4	9	ng	ng	PROPN
ecj-12574	4	10	/	/	SYM
ecj-12574	4	11	ml	ml	PROPN
ecj-12574	4	12	(	(	PUNCT
ecj-12574	4	13	50	50	NUM
ecj-12574	4	14	-	-	SYM
ecj-12574	4	15	110	110	NUM
ecj-12574	4	16	ng	ng	PROPN
ecj-12574	4	17	/	/	SYM
ecj-12574	4	18	ml	ml	NOUN
ecj-12574	4	19	)	)	PUNCT
ecj-12574	4	20	.	.	PUNCT
ecj-12574	5	1	mri	mri	NOUN
ecj-12574	5	2	revealed	reveal	VERB
ecj-12574	5	3	a	a	DET
ecj-12574	5	4	transient	transient	ADJ
ecj-12574	5	5	bilateral	bilateral	ADJ
ecj-12574	5	6	caudate	caudate	NOUN
ecj-12574	5	7	and	and	CCONJ
ecj-12574	5	8	putamen	putaman	NOUN
ecj-12574	5	9	hyperintensity	hyperintensity	NOUN
ecj-12574	5	10	,	,	PUNCT
ecj-12574	5	11	associated	associate	VERB
ecj-12574	5	12	to	to	ADP
ecj-12574	5	13	an	an	DET
ecj-12574	5	14	occipital	occipital	NOUN
ecj-12574	5	15	cortical	cortical	ADJ
ecj-12574	5	16	and	and	CCONJ
ecj-12574	5	17	subcortical	subcortical	ADJ
ecj-12574	5	18	hyperintensity	hyperintensity	NOUN
ecj-12574	5	19	.	.	PUNCT
ecj-12574	6	1	she	she	PRON
ecj-12574	6	2	was	be	AUX
ecj-12574	6	3	treated	treat	VERB
ecj-12574	6	4	with	with	ADP
ecj-12574	6	5	iv	iv	NUM
ecj-12574	6	6	cyproheptadine	cyproheptadine	NOUN
ecj-12574	6	7	with	with	ADP
ecj-12574	6	8	progressive	progressive	ADJ
ecj-12574	6	9	benefit	benefit	NOUN
ecj-12574	6	10	in	in	ADP
ecj-12574	6	11	few	few	ADJ
ecj-12574	6	12	days	day	NOUN
ecj-12574	6	13	.	.	PUNCT
ecj-12574	7	1	only	only	ADV
ecj-12574	7	2	4	4	NUM
ecj-12574	7	3	children	child	NOUN
ecj-12574	7	4	with	with	ADP
ecj-12574	7	5	citalopram	citalopram	PROPN
ecj-12574	7	6	intoxication	intoxication	NOUN
ecj-12574	7	7	are	be	AUX
ecj-12574	7	8	previously	previously	ADV
ecj-12574	7	9	described	describe	VERB
ecj-12574	7	10	with	with	ADP
ecj-12574	7	11	neurological	neurological	ADJ
ecj-12574	7	12	involvement	involvement	NOUN
ecj-12574	7	13	.	.	PUNCT
ecj-12574	8	1	pediatric	pediatric	ADJ
ecj-12574	8	2	citalopram	citalopram	PROPN
ecj-12574	8	3	intoxication	intoxication	NOUN
ecj-12574	8	4	could	could	AUX
ecj-12574	8	5	cause	cause	VERB
ecj-12574	8	6	ss	ss	NOUN
ecj-12574	8	7	leading	lead	VERB
ecj-12574	8	8	to	to	ADP
ecj-12574	8	9	pres	pre	NOUN
ecj-12574	8	10	,	,	PUNCT
ecj-12574	8	11	and	and	CCONJ
ecj-12574	8	12	cyproheptadine	cyproheptadine	NOUN
ecj-12574	8	13	could	could	AUX
ecj-12574	8	14	be	be	AUX
ecj-12574	8	15	used	use	VERB
ecj-12574	8	16	with	with	ADP
ecj-12574	8	17	benefit	benefit	NOUN
ecj-12574	8	18	.	.	PUNCT
ecj-12574	9	1	introduction	introduction	NOUN
ecj-12574	9	2	citalopram	citalopram	PROPN
ecj-12574	9	3	is	be	AUX
ecj-12574	9	4	a	a	DET
ecj-12574	9	5	selective	selective	ADJ
ecj-12574	9	6	serotonin	serotonin	NOUN
ecj-12574	9	7	reuptake	reuptake	NOUN
ecj-12574	9	8	inhibitors	inhibitor	NOUN
ecj-12574	9	9	(	(	PUNCT
ecj-12574	9	10	ssris	ssris	NOUN
ecj-12574	9	11	)	)	PUNCT
ecj-12574	9	12	used	use	VERB
ecj-12574	9	13	in	in	ADP
ecj-12574	9	14	adults	adult	NOUN
ecj-12574	9	15	to	to	PART
ecj-12574	9	16	treat	treat	VERB
ecj-12574	9	17	major	major	ADJ
ecj-12574	9	18	depressive	depressive	ADJ
ecj-12574	9	19	disorder	disorder	NOUN
ecj-12574	9	20	,	,	PUNCT
ecj-12574	9	21	obsessive	obsessive	ADJ
ecj-12574	9	22	compulsive	compulsive	ADJ
ecj-12574	9	23	disorders	disorder	NOUN
ecj-12574	9	24	,	,	PUNCT
ecj-12574	9	25	panic	panic	NOUN
ecj-12574	9	26	disorder	disorder	NOUN
ecj-12574	9	27	,	,	PUNCT
ecj-12574	9	28	anxiety	anxiety	NOUN
ecj-12574	9	29	disorders	disorder	NOUN
ecj-12574	9	30	,	,	PUNCT
ecj-12574	9	31	posttraumatic	posttraumatic	ADJ
ecj-12574	9	32	stress	stress	NOUN
ecj-12574	9	33	disorder.1	disorder.1	VERB
ecj-12574	9	34	the	the	DET
ecj-12574	9	35	daily	daily	ADJ
ecj-12574	9	36	therapeutic	therapeutic	ADJ
ecj-12574	9	37	dose	dose	NOUN
ecj-12574	9	38	of	of	ADP
ecj-12574	9	39	citalopram	citalopram	PROPN
ecj-12574	9	40	is	be	AUX
ecj-12574	9	41	20	20	NUM
ecj-12574	9	42	-	-	SYM
ecj-12574	9	43	60	60	NUM
ecj-12574	9	44	mg	mg	NUM
ecj-12574	9	45	/	/	SYM
ecj-12574	9	46	day	day	NOUN
ecj-12574	9	47	and	and	CCONJ
ecj-12574	9	48	it	it	PRON
ecj-12574	9	49	is	be	AUX
ecj-12574	9	50	used	use	VERB
ecj-12574	9	51	as	as	ADP
ecj-12574	9	52	off	off	ADP
ecj-12574	9	53	-	-	PUNCT
ecj-12574	9	54	label	label	NOUN
ecj-12574	9	55	in	in	ADP
ecj-12574	9	56	pediatric	pediatric	ADJ
ecj-12574	9	57	patients.2	patients.2	NOUN
ecj-12574	9	58	the	the	DET
ecj-12574	9	59	most	most	ADV
ecj-12574	9	60	common	common	ADJ
ecj-12574	9	61	side	side	NOUN
ecj-12574	9	62	effects	effect	NOUN
ecj-12574	9	63	include	include	VERB
ecj-12574	9	64	tiredness	tiredness	NOUN
ecj-12574	9	65	,	,	PUNCT
ecj-12574	9	66	confusion	confusion	NOUN
ecj-12574	9	67	,	,	PUNCT
ecj-12574	9	68	dizziness	dizziness	NOUN
ecj-12574	9	69	,	,	PUNCT
ecj-12574	9	70	stomach	stomach	NOUN
ecj-12574	9	71	pain	pain	NOUN
ecj-12574	9	72	,	,	PUNCT
ecj-12574	9	73	sweating	sweating	NOUN
ecj-12574	9	74	,	,	PUNCT
ecj-12574	9	75	nausea	nausea	NOUN
ecj-12574	9	76	,	,	PUNCT
ecj-12574	9	77	sinus	sinus	NOUN
ecj-12574	9	78	tachycardia	tachycardia	NOUN
ecj-12574	9	79	and	and	CCONJ
ecj-12574	9	80	tremor,3	tremor,3	NOUN
ecj-12574	9	81	but	but	CCONJ
ecj-12574	9	82	it	it	PRON
ecj-12574	9	83	can	can	AUX
ecj-12574	9	84	also	also	ADV
ecj-12574	9	85	cause	cause	VERB
ecj-12574	9	86	serotonin	serotonin	NOUN
ecj-12574	9	87	syndrome	syndrome	NOUN
ecj-12574	9	88	(	(	PUNCT
ecj-12574	9	89	ss	ss	NOUN
ecj-12574	9	90	)	)	PUNCT
ecj-12574	9	91	characterized	characterize	VERB
ecj-12574	9	92	by	by	ADP
ecj-12574	9	93	altered	alter	VERB
ecj-12574	9	94	mental	mental	ADJ
ecj-12574	9	95	status	status	NOUN
ecj-12574	9	96	,	,	PUNCT
ecj-12574	9	97	anxiety	anxiety	NOUN
ecj-12574	9	98	,	,	PUNCT
ecj-12574	9	99	confusion	confusion	NOUN
ecj-12574	9	100	,	,	PUNCT
ecj-12574	9	101	agitation	agitation	NOUN
ecj-12574	9	102	,	,	PUNCT
ecj-12574	9	103	hallucinations	hallucination	NOUN
ecj-12574	9	104	,	,	PUNCT
ecj-12574	9	105	coma	coma	NOUN
ecj-12574	9	106	,	,	PUNCT
ecj-12574	9	107	seizures	seizure	NOUN
ecj-12574	9	108	,	,	PUNCT
ecj-12574	9	109	autonomic	autonomic	ADJ
ecj-12574	9	110	instability	instability	NOUN
ecj-12574	9	111	and	and	CCONJ
ecj-12574	9	112	extrapyramidal	extrapyramidal	ADJ
ecj-12574	9	113	signs	sign	NOUN
ecj-12574	9	114	.	.	PUNCT
ecj-12574	10	1	among	among	ADP
ecj-12574	10	2	ssris	ssris	PROPN
ecj-12574	10	3	,	,	PUNCT
ecj-12574	10	4	citalopram	citalopram	PROPN
ecj-12574	10	5	has	have	VERB
ecj-12574	10	6	a	a	DET
ecj-12574	10	7	high	high	ADJ
ecj-12574	10	8	rate	rate	NOUN
ecj-12574	10	9	of	of	ADP
ecj-12574	10	10	seizures	seizure	NOUN
ecj-12574	10	11	in	in	ADP
ecj-12574	10	12	overdose	overdose	ADJ
ecj-12574	10	13	and	and	CCONJ
ecj-12574	10	14	cardiac	cardiac	ADJ
ecj-12574	10	15	toxicity	toxicity	NOUN
ecj-12574	10	16	,	,	PUNCT
ecj-12574	10	17	most	most	ADJ
ecj-12574	10	18	of	of	ADP
ecj-12574	10	19	all	all	PRON
ecj-12574	10	20	in	in	ADP
ecj-12574	10	21	doses	dose	NOUN
ecj-12574	10	22	higher	high	ADJ
ecj-12574	10	23	than	than	ADP
ecj-12574	10	24	400mg	400mg	NOUN
ecj-12574	10	25	/	/	SYM
ecj-12574	10	26	day.4,5	day.4,5	NOUN
ecj-12574	10	27	posterior	posterior	ADJ
ecj-12574	10	28	reversible	reversible	ADJ
ecj-12574	10	29	encephalopathy	encephalopathy	ADJ
ecj-12574	10	30	syndrome	syndrome	NOUN
ecj-12574	10	31	(	(	PUNCT
ecj-12574	10	32	pres	pre	NOUN
ecj-12574	10	33	)	)	PUNCT
ecj-12574	10	34	is	be	AUX
ecj-12574	10	35	described	describe	VERB
ecj-12574	10	36	in	in	ADP
ecj-12574	10	37	adult	adult	NOUN
ecj-12574	10	38	patients	patient	NOUN
ecj-12574	10	39	with	with	ADP
ecj-12574	10	40	ssri	ssri	PROPN
ecj-12574	10	41	accidental	accidental	PROPN
ecj-12574	10	42	ingestions.6	ingestions.6	PROPN
ecj-12574	10	43	-	-	SYM
ecj-12574	10	44	9	9	NUM
ecj-12574	10	45	when	when	SCONJ
ecj-12574	10	46	ss	ss	PROPN
ecj-12574	10	47	occurs	occur	VERB
ecj-12574	10	48	in	in	ADP
ecj-12574	10	49	adults	adult	NOUN
ecj-12574	10	50	,	,	PUNCT
ecj-12574	10	51	cyproheptadine	cyproheptadine	NOUN
ecj-12574	10	52	is	be	AUX
ecj-12574	10	53	used	use	VERB
ecj-12574	10	54	as	as	ADP
ecj-12574	10	55	an	an	DET
ecj-12574	10	56	antidote	antidote	NOUN
ecj-12574	10	57	(	(	PUNCT
ecj-12574	10	58	12	12	NUM
ecj-12574	10	59	-	-	SYM
ecj-12574	10	60	32	32	NUM
ecj-12574	10	61	mg	mg	PROPN
ecj-12574	10	62	/	/	SYM
ecj-12574	10	63	day).10	day).10	NOUN
ecj-12574	10	64	within	within	ADP
ecj-12574	10	65	this	this	DET
ecj-12574	10	66	context	context	NOUN
ecj-12574	10	67	,	,	PUNCT
ecj-12574	10	68	we	we	PRON
ecj-12574	10	69	review	review	VERB
ecj-12574	10	70	the	the	DET
ecj-12574	10	71	literature	literature	NOUN
ecj-12574	10	72	on	on	ADP
ecj-12574	10	73	pediatric	pediatric	ADJ
ecj-12574	10	74	citalopram	citalopram	PROPN
ecj-12574	10	75	intoxication	intoxication	NOUN
ecj-12574	10	76	and	and	CCONJ
ecj-12574	10	77	we	we	PRON
ecj-12574	10	78	describe	describe	VERB
ecj-12574	10	79	the	the	DET
ecj-12574	10	80	first	first	ADJ
ecj-12574	10	81	case	case	NOUN
ecj-12574	10	82	of	of	ADP
ecj-12574	10	83	pediatric	pediatric	ADJ
ecj-12574	10	84	ss	ss	NOUN
ecj-12574	10	85	with	with	ADP
ecj-12574	10	86	pres	pre	NOUN
ecj-12574	10	87	after	after	ADP
ecj-12574	10	88	accidental	accidental	ADJ
ecj-12574	10	89	ingestion	ingestion	NOUN
ecj-12574	10	90	of	of	ADP
ecj-12574	10	91	an	an	DET
ecj-12574	10	92	unspecified	unspecified	ADJ
ecj-12574	10	93	dose	dose	NOUN
ecj-12574	10	94	of	of	ADP
ecj-12574	10	95	this	this	DET
ecj-12574	10	96	drug	drug	NOUN
ecj-12574	10	97	treated	treat	VERB
ecj-12574	10	98	with	with	ADP
ecj-12574	10	99	cyproheptadine	cyproheptadine	NOUN
ecj-12574	10	100	.	.	PUNCT
ecj-12574	11	1	the	the	DET
ecj-12574	11	2	review	review	NOUN
ecj-12574	11	3	was	be	AUX
ecj-12574	11	4	conducted	conduct	VERB
ecj-12574	11	5	in	in	ADP
ecj-12574	11	6	accordance	accordance	NOUN
ecj-12574	11	7	with	with	ADP
ecj-12574	11	8	the	the	DET
ecj-12574	11	9	preferred	preferred	ADJ
ecj-12574	11	10	reporting	reporting	NOUN
ecj-12574	11	11	items	item	NOUN
ecj-12574	11	12	for	for	ADP
ecj-12574	11	13	systematic	systematic	ADJ
ecj-12574	11	14	reviews	review	NOUN
ecj-12574	11	15	and	and	CCONJ
ecj-12574	11	16	meta	meta	NOUN
ecj-12574	11	17	-	-	PUNCT
ecj-12574	11	18	analyses	analysis	NOUN
ecj-12574	11	19	(	(	PUNCT
ecj-12574	11	20	prisma	prisma	NOUN
ecj-12574	11	21	)	)	PUNCT
ecj-12574	11	22	guidelines	guideline	NOUN
ecj-12574	11	23	2021	2021	NUM
ecj-12574	11	24	,	,	PUNCT
ecj-12574	11	25	used	use	VERB
ecj-12574	11	26	in	in	ADP
ecj-12574	11	27	conjunction	conjunction	NOUN
ecj-12574	11	28	with	with	ADP
ecj-12574	11	29	the	the	DET
ecj-12574	11	30	explanation	explanation	NOUN
ecj-12574	11	31	and	and	CCONJ
ecj-12574	11	32	elaboration	elaboration	NOUN
ecj-12574	11	33	document	document	NOUN
ecj-12574	11	34	and	and	CCONJ
ecj-12574	11	35	the	the	DET
ecj-12574	11	36	prisma	prisma	NOUN
ecj-12574	11	37	-	-	PUNCT
ecj-12574	11	38	s	s	NOUN
ecj-12574	11	39	extension	extension	NOUN
ecj-12574	11	40	to	to	ADP
ecj-12574	11	41	the	the	DET
ecj-12574	11	42	prisma	prisma	NOUN
ecj-12574	11	43	statement	statement	NOUN
ecj-12574	11	44	for	for	ADP
ecj-12574	11	45	reporting	report	VERB
ecj-12574	11	46	literature	literature	NOUN
ecj-12574	11	47	searches	search	NOUN
ecj-12574	11	48	in	in	ADP
ecj-12574	11	49	systematic	systematic	ADJ
ecj-12574	11	50	reviews.11,12	reviews.11,12	NOUN
ecj-12574	11	51	we	we	PRON
ecj-12574	11	52	performed	perform	VERB
ecj-12574	11	53	a	a	DET
ecj-12574	11	54	search	search	NOUN
ecj-12574	11	55	using	use	VERB
ecj-12574	11	56	medline	medline	NOUN
ecj-12574	11	57	via	via	ADP
ecj-12574	11	58	the	the	DET
ecj-12574	11	59	pubmed	pubmed	PROPN
ecj-12574	11	60	interface	interface	PROPN
ecj-12574	11	61	for	for	ADP
ecj-12574	11	62	original	original	ADJ
ecj-12574	11	63	studies	study	NOUN
ecj-12574	11	64	(	(	PUNCT
ecj-12574	11	65	figure	figure	NOUN
ecj-12574	11	66	1	1	NUM
ecj-12574	11	67	)	)	PUNCT
ecj-12574	11	68	.	.	PUNCT
ecj-12574	12	1	references	reference	NOUN
ecj-12574	12	2	were	be	AUX
ecj-12574	12	3	identified	identify	VERB
ecj-12574	12	4	from	from	ADP
ecj-12574	12	5	pubmed	pubmed	PROPN
ecj-12574	12	6	searches	search	NOUN
ecj-12574	12	7	from	from	ADP
ecj-12574	12	8	1990	1990	NUM
ecj-12574	12	9	to	to	ADP
ecj-12574	12	10	2023	2023	NUM
ecj-12574	12	11	.	.	PUNCT
ecj-12574	13	1	we	we	PRON
ecj-12574	13	2	combined	combine	VERB
ecj-12574	13	3	emergency	emergency	NOUN
ecj-12574	13	4	care	care	NOUN
ecj-12574	13	5	journal	journal	PROPN
ecj-12574	13	6	2024	2024	NUM
ecj-12574	13	7	;	;	PUNCT
ecj-12574	13	8	volume	volume	NOUN
ecj-12574	13	9	20:12574	20:12574	NUM
ecj-12574	14	1	[	[	X
ecj-12574	14	2	emergency	emergency	NOUN
ecj-12574	14	3	care	care	NOUN
ecj-12574	14	4	journal	journal	PROPN
ecj-12574	14	5	2024	2024	NUM
ecj-12574	14	6	;	;	PUNCT
ecj-12574	14	7	20:12574	20:12574	NUM
ecj-12574	14	8	]	]	X
ecj-12574	15	1	[	[	X
ecj-12574	15	2	page	page	NOUN
ecj-12574	15	3	65	65	NUM
ecj-12574	15	4	]	]	X
ecj-12574	15	5	neurotoxicity	neurotoxicity	NOUN
ecj-12574	15	6	and	and	CCONJ
ecj-12574	15	7	pres	pre	NOUN
ecj-12574	15	8	after	after	ADP
ecj-12574	15	9	severe	severe	ADJ
ecj-12574	15	10	citalopram	citalopram	PROPN
ecj-12574	15	11	intoxication	intoxication	NOUN
ecj-12574	15	12	in	in	ADP
ecj-12574	15	13	a	a	DET
ecj-12574	15	14	12	12	NUM
ecj-12574	15	15	-	-	PUNCT
ecj-12574	15	16	months	month	NOUN
ecj-12574	15	17	-	-	PUNCT
ecj-12574	15	18	old	old	ADJ
ecj-12574	15	19	baby	baby	NOUN
ecj-12574	15	20	sara	sara	NOUN
ecj-12574	15	21	minghetti,¹	minghetti,¹	NOUN
ecj-12574	15	22	alessandra	alessandra	PROPN
ecj-12574	15	23	lazzerotti,²	lazzerotti,²	X
ecj-12574	15	24	debora	debora	PROPN
ecj-12574	15	25	sala,²	sala,²	NOUN
ecj-12574	15	26	chiara	chiara	PROPN
ecj-12574	15	27	vimercati,²	vimercati,²	PROPN
ecj-12574	15	28	sofia	sofia	PROPN
ecj-12574	15	29	giudici,2,3	giudici,2,3	PROPN
ecj-12574	15	30	santa	santa	PROPN
ecj-12574	15	31	florio,4	florio,4	PROPN
ecj-12574	15	32	francesca	francesca	PROPN
ecj-12574	15	33	formica,5	formica,5	NOUN
ecj-12574	15	34	stefania	stefania	PROPN
ecj-12574	15	35	zambrano,6	zambrano,6	NOUN
ecj-12574	15	36	nivedita	nivedita	PROPN
ecj-12574	15	37	agarwal,7	agarwal,7	NOUN
ecj-12574	15	38	cinzia	cinzia	NOUN
ecj-12574	15	39	peruzzi¹	peruzzi¹	VERB
ecj-12574	16	1	¹pediatric	¹pediatric	ADJ
ecj-12574	16	2	neurology	neurology	NOUN
ecj-12574	16	3	and	and	CCONJ
ecj-12574	16	4	psychiatry	psychiatry	NOUN
ecj-12574	16	5	department	department	PROPN
ecj-12574	16	6	,	,	PUNCT
ecj-12574	16	7	fondazione	fondazione	PROPN
ecj-12574	16	8	irccs	ircc	VERB
ecj-12574	16	9	san	san	PROPN
ecj-12574	16	10	gerardo	gerardo	PROPN
ecj-12574	16	11	dei	dei	PROPN
ecj-12574	16	12	tintori	tintori	PROPN
ecj-12574	16	13	monza	monza	PROPN
ecj-12574	16	14	;	;	PUNCT
ecj-12574	16	15	²pediatric	²pediatric	PROPN
ecj-12574	16	16	department	department	NOUN
ecj-12574	16	17	,	,	PUNCT
ecj-12574	16	18	fondazione	fondazione	NOUN
ecj-12574	16	19	mbbm	mbbm	NOUN
ecj-12574	16	20	,	,	PUNCT
ecj-12574	16	21	fondazione	fondazione	PROPN
ecj-12574	16	22	irccs	ircc	VERB
ecj-12574	16	23	san	san	PROPN
ecj-12574	16	24	gerardo	gerardo	PROPN
ecj-12574	16	25	dei	dei	PROPN
ecj-12574	16	26	tintori	tintori	PROPN
ecj-12574	16	27	monza	monza	PROPN
ecj-12574	16	28	;	;	PUNCT
ecj-12574	16	29	³school	³school	ADP
ecj-12574	16	30	of	of	ADP
ecj-12574	16	31	medicine	medicine	NOUN
ecj-12574	16	32	and	and	CCONJ
ecj-12574	16	33	surgery	surgery	NOUN
ecj-12574	16	34	,	,	PUNCT
ecj-12574	16	35	milano	milano	PROPN
ecj-12574	16	36	bicocca	bicocca	PROPN
ecj-12574	16	37	university	university	NOUN
ecj-12574	16	38	;	;	PUNCT
ecj-12574	16	39	4neuroimaging	4neuroimaging	NUM
ecj-12574	16	40	unit	unit	NOUN
ecj-12574	16	41	,	,	PUNCT
ecj-12574	16	42	fondazione	fondazione	PROPN
ecj-12574	16	43	irccs	ircc	VERB
ecj-12574	16	44	san	san	PROPN
ecj-12574	16	45	gerardo	gerardo	PROPN
ecj-12574	16	46	dei	dei	PROPN
ecj-12574	16	47	tintori	tintori	PROPN
ecj-12574	16	48	,	,	PUNCT
ecj-12574	16	49	monza	monza	PROPN
ecj-12574	16	50	;	;	PUNCT
ecj-12574	16	51	5neuropsychiatry	5neuropsychiatry	NUM
ecj-12574	16	52	and	and	CCONJ
ecj-12574	16	53	neurorehabilitation	neurorehabilitation	NOUN
ecj-12574	16	54	unit	unit	NOUN
ecj-12574	16	55	,	,	PUNCT
ecj-12574	16	56	scientific	scientific	ADJ
ecj-12574	16	57	institute	institute	NOUN
ecj-12574	16	58	,	,	PUNCT
ecj-12574	16	59	irccs	irccs	PROPN
ecj-12574	16	60	eugenio	eugenio	PROPN
ecj-12574	16	61	medea	medea	PROPN
ecj-12574	16	62	,	,	PUNCT
ecj-12574	16	63	bosisio	bosisio	ADJ
ecj-12574	16	64	parini	parini	NOUN
ecj-12574	16	65	,	,	PUNCT
ecj-12574	16	66	lecco	lecco	PROPN
ecj-12574	16	67	;	;	PUNCT
ecj-12574	16	68	6clinical	6clinical	NUM
ecj-12574	16	69	neurophysiology	neurophysiology	NOUN
ecj-12574	16	70	unit	unit	NOUN
ecj-12574	16	71	,	,	PUNCT
ecj-12574	16	72	scientific	scientific	ADJ
ecj-12574	16	73	institute	institute	NOUN
ecj-12574	16	74	,	,	PUNCT
ecj-12574	16	75	irccs	irccs	PROPN
ecj-12574	16	76	eugenio	eugenio	PROPN
ecj-12574	16	77	medea	medea	PROPN
ecj-12574	16	78	,	,	PUNCT
ecj-12574	16	79	bosisio	bosisio	ADJ
ecj-12574	16	80	parini	parini	PROPN
ecj-12574	16	81	,	,	PUNCT
ecj-12574	16	82	lecco	lecco	PROPN
ecj-12574	16	83	;	;	PUNCT
ecj-12574	16	84	7neuroimaging	7neuroimage	VERB
ecj-12574	16	85	unit	unit	NOUN
ecj-12574	16	86	,	,	PUNCT
ecj-12574	16	87	scientific	scientific	ADJ
ecj-12574	16	88	institute	institute	NOUN
ecj-12574	16	89	irccs	ircc	VERB
ecj-12574	16	90	e.	e.	PROPN
ecj-12574	16	91	medea	medea	PROPN
ecj-12574	16	92	,	,	PUNCT
ecj-12574	16	93	bosisio	bosisio	ADJ
ecj-12574	16	94	parini	parini	PROPN
ecj-12574	16	95	,	,	PUNCT
ecj-12574	16	96	lecco	lecco	PROPN
ecj-12574	16	97	,	,	PUNCT
ecj-12574	16	98	italy	italy	PROPN
ecj-12574	16	99	correspondence	correspondence	NOUN
ecj-12574	16	100	:	:	PUNCT
ecj-12574	16	101	sara	sara	PROPN
ecj-12574	16	102	minghetti	minghetti	PROPN
ecj-12574	16	103	,	,	PUNCT
ecj-12574	16	104	pediatric	pediatric	ADJ
ecj-12574	16	105	neurology	neurology	NOUN
ecj-12574	16	106	and	and	CCONJ
ecj-12574	16	107	psychiatry	psychiatry	NOUN
ecj-12574	16	108	department	department	PROPN
ecj-12574	16	109	,	,	PUNCT
ecj-12574	16	110	fondazione	fondazione	PROPN
ecj-12574	16	111	irccs	ircc	VERB
ecj-12574	16	112	san	san	PROPN
ecj-12574	16	113	gerardo	gerardo	PROPN
ecj-12574	16	114	dei	dei	PROPN
ecj-12574	16	115	tintori	tintori	PROPN
ecj-12574	16	116	,	,	PUNCT
ecj-12574	16	117	20900	20900	NUM
ecj-12574	16	118	monza	monza	NOUN
ecj-12574	16	119	,	,	PUNCT
ecj-12574	16	120	via	via	ADP
ecj-12574	16	121	pergolesi	pergolesi	NOUN
ecj-12574	16	122	33	33	NUM
ecj-12574	16	123	,	,	PUNCT
ecj-12574	16	124	italy	italy	PROPN
ecj-12574	16	125	.	.	PUNCT
ecj-12574	17	1	e	e	X
ecj-12574	17	2	-	-	NOUN
ecj-12574	17	3	mail	mail	NOUN
ecj-12574	17	4	:	:	PUNCT
ecj-12574	17	5	sara.minghetti@irccs-sangerardo.it	sara.minghetti@irccs-sangerardo.it	PROPN
ecj-12574	17	6	key	key	ADJ
ecj-12574	17	7	words	word	NOUN
ecj-12574	17	8	:	:	PUNCT
ecj-12574	17	9	citalopram	citalopram	PROPN
ecj-12574	17	10	intoxication	intoxication	NOUN
ecj-12574	17	11	;	;	PUNCT
ecj-12574	17	12	serotonin	serotonin	NOUN
ecj-12574	17	13	syndrome	syndrome	NOUN
ecj-12574	17	14	;	;	PUNCT
ecj-12574	17	15	posterior	posterior	ADJ
ecj-12574	17	16	reversible	reversible	ADJ
ecj-12574	17	17	encephalopathy	encephalopathy	ADJ
ecj-12574	17	18	syndrome	syndrome	NOUN
ecj-12574	17	19	;	;	PUNCT
ecj-12574	17	20	cyproheptadine	cyproheptadine	NOUN
ecj-12574	17	21	.	.	PUNCT
ecj-12574	18	1	conflict	conflict	NOUN
ecj-12574	18	2	of	of	ADP
ecj-12574	18	3	interest	interest	NOUN
ecj-12574	18	4	:	:	PUNCT
ecj-12574	18	5	the	the	DET
ecj-12574	18	6	authors	author	NOUN
ecj-12574	18	7	declare	declare	VERB
ecj-12574	18	8	no	no	DET
ecj-12574	18	9	potential	potential	ADJ
ecj-12574	18	10	conflict	conflict	NOUN
ecj-12574	18	11	of	of	ADP
ecj-12574	18	12	interest	interest	NOUN
ecj-12574	18	13	,	,	PUNCT
ecj-12574	18	14	and	and	CCONJ
ecj-12574	18	15	all	all	DET
ecj-12574	18	16	authors	author	NOUN
ecj-12574	18	17	confirm	confirm	VERB
ecj-12574	18	18	accuracy	accuracy	NOUN
ecj-12574	18	19	.	.	PUNCT
ecj-12574	19	1	contributions	contribution	NOUN
ecj-12574	19	2	:	:	PUNCT
ecj-12574	20	1	sm	sm	NOUN
ecj-12574	20	2	and	and	CCONJ
ecj-12574	20	3	sg	sg	PROPN
ecj-12574	20	4	wrote	write	VERB
ecj-12574	20	5	the	the	DET
ecj-12574	20	6	paper	paper	NOUN
ecj-12574	20	7	,	,	PUNCT
ecj-12574	20	8	cv	cv	PROPN
ecj-12574	20	9	,	,	PUNCT
ecj-12574	20	10	al	al	PROPN
ecj-12574	20	11	,	,	PUNCT
ecj-12574	20	12	ds	ds	ADJ
ecj-12574	20	13	,	,	PUNCT
ecj-12574	20	14	ff	ff	NOUN
ecj-12574	20	15	and	and	CCONJ
ecj-12574	20	16	cp	cp	PROPN
ecj-12574	20	17	reviewed	review	VERB
ecj-12574	20	18	the	the	DET
ecj-12574	20	19	paper	paper	NOUN
ecj-12574	20	20	.	.	PUNCT
ecj-12574	21	1	sf	sf	NOUN
ecj-12574	21	2	and	and	CCONJ
ecj-12574	21	3	na	na	AUX
ecj-12574	21	4	reviewed	review	VERB
ecj-12574	21	5	the	the	DET
ecj-12574	21	6	mri	mri	NOUN
ecj-12574	21	7	figure	figure	NOUN
ecj-12574	21	8	,	,	PUNCT
ecj-12574	21	9	sz	sz	PROPN
ecj-12574	21	10	the	the	DET
ecj-12574	21	11	eeg	eeg	NOUN
ecj-12574	21	12	figure	figure	NOUN
ecj-12574	21	13	.	.	PUNCT
ecj-12574	22	1	no	no	DET
ecj-12574	22	2	artificial	artificial	ADJ
ecj-12574	22	3	intelligence	intelligence	NOUN
ecj-12574	22	4	assisted	assist	VERB
ecj-12574	22	5	-	-	PUNCT
ecj-12574	22	6	tecnologies	tecnologie	NOUN
ecj-12574	22	7	were	be	AUX
ecj-12574	22	8	used	use	VERB
ecj-12574	22	9	to	to	PART
ecj-12574	22	10	write	write	VERB
ecj-12574	22	11	this	this	DET
ecj-12574	22	12	paper	paper	NOUN
ecj-12574	22	13	.	.	PUNCT
ecj-12574	23	1	ethics	ethic	NOUN
ecj-12574	23	2	approval	approval	NOUN
ecj-12574	23	3	and	and	CCONJ
ecj-12574	23	4	consent	consent	NOUN
ecj-12574	23	5	to	to	PART
ecj-12574	23	6	participate	participate	VERB
ecj-12574	23	7	:	:	PUNCT
ecj-12574	23	8	no	no	DET
ecj-12574	23	9	ethical	ethical	ADJ
ecj-12574	23	10	committee	committee	NOUN
ecj-12574	23	11	approval	approval	NOUN
ecj-12574	23	12	was	be	AUX
ecj-12574	23	13	required	require	VERB
ecj-12574	23	14	for	for	ADP
ecj-12574	23	15	this	this	DET
ecj-12574	23	16	case	case	NOUN
ecj-12574	23	17	report	report	NOUN
ecj-12574	23	18	by	by	ADP
ecj-12574	23	19	the	the	DET
ecj-12574	23	20	department	department	NOUN
ecj-12574	23	21	,	,	PUNCT
ecj-12574	23	22	because	because	SCONJ
ecj-12574	23	23	this	this	DET
ecj-12574	23	24	article	article	NOUN
ecj-12574	23	25	does	do	AUX
ecj-12574	23	26	not	not	PART
ecj-12574	23	27	contain	contain	VERB
ecj-12574	23	28	any	any	DET
ecj-12574	23	29	studies	study	NOUN
ecj-12574	23	30	with	with	ADP
ecj-12574	23	31	human	human	ADJ
ecj-12574	23	32	participants	participant	NOUN
ecj-12574	23	33	or	or	CCONJ
ecj-12574	23	34	animals	animal	NOUN
ecj-12574	23	35	.	.	PUNCT
ecj-12574	24	1	informed	inform	VERB
ecj-12574	24	2	consent	consent	NOUN
ecj-12574	24	3	was	be	AUX
ecj-12574	24	4	obtained	obtain	VERB
ecj-12574	24	5	from	from	ADP
ecj-12574	24	6	the	the	DET
ecj-12574	24	7	patient	patient	NOUN
ecj-12574	24	8	included	include	VERB
ecj-12574	24	9	in	in	ADP
ecj-12574	24	10	this	this	DET
ecj-12574	24	11	study	study	NOUN
ecj-12574	24	12	.	.	PUNCT
ecj-12574	25	1	patient	patient	ADJ
ecj-12574	25	2	consent	consent	NOUN
ecj-12574	25	3	for	for	ADP
ecj-12574	25	4	publication	publication	NOUN
ecj-12574	25	5	:	:	PUNCT
ecj-12574	25	6	the	the	DET
ecj-12574	25	7	patient	patient	NOUN
ecj-12574	25	8	’s	’s	PART
ecj-12574	25	9	guardian	guardian	PROPN
ecj-12574	25	10	/	/	SYM
ecj-12574	25	11	s	s	VERB
ecj-12574	25	12	gave	give	VERB
ecj-12574	25	13	their	their	PRON
ecj-12574	25	14	written	write	VERB
ecj-12574	25	15	consent	consent	NOUN
ecj-12574	25	16	to	to	PART
ecj-12574	25	17	use	use	VERB
ecj-12574	25	18	the	the	DET
ecj-12574	25	19	patient	patient	NOUN
ecj-12574	25	20	’s	’s	PART
ecj-12574	25	21	personal	personal	ADJ
ecj-12574	25	22	data	datum	NOUN
ecj-12574	25	23	for	for	ADP
ecj-12574	25	24	the	the	DET
ecj-12574	25	25	publication	publication	NOUN
ecj-12574	25	26	of	of	ADP
ecj-12574	25	27	this	this	DET
ecj-12574	25	28	case	case	NOUN
ecj-12574	25	29	report	report	NOUN
ecj-12574	25	30	and	and	CCONJ
ecj-12574	25	31	any	any	DET
ecj-12574	25	32	accompanying	accompanying	ADJ
ecj-12574	25	33	images	image	NOUN
ecj-12574	25	34	.	.	PUNCT
ecj-12574	26	1	availability	availability	NOUN
ecj-12574	26	2	of	of	ADP
ecj-12574	26	3	data	datum	NOUN
ecj-12574	26	4	and	and	CCONJ
ecj-12574	26	5	materials	material	NOUN
ecj-12574	26	6	:	:	PUNCT
ecj-12574	26	7	all	all	DET
ecj-12574	26	8	data	datum	NOUN
ecj-12574	26	9	underlying	underlie	VERB
ecj-12574	26	10	the	the	DET
ecj-12574	26	11	findings	finding	NOUN
ecj-12574	26	12	are	be	AUX
ecj-12574	26	13	fully	fully	ADV
ecj-12574	26	14	available	available	ADJ
ecj-12574	26	15	.	.	PUNCT
ecj-12574	27	1	received	receive	VERB
ecj-12574	27	2	:	:	PUNCT
ecj-12574	27	3	15	15	NUM
ecj-12574	27	4	april	april	PROPN
ecj-12574	27	5	2024	2024	NUM
ecj-12574	27	6	.	.	PUNCT
ecj-12574	28	1	accepted	accept	VERB
ecj-12574	28	2	:	:	PUNCT
ecj-12574	28	3	9	9	NUM
ecj-12574	28	4	august	august	PROPN
ecj-12574	28	5	2024	2024	NUM
ecj-12574	28	6	.	.	PUNCT
ecj-12574	29	1	early	early	ADJ
ecj-12574	29	2	view	view	NOUN
ecj-12574	29	3	:	:	PUNCT
ecj-12574	29	4	2	2	NUM
ecj-12574	29	5	september	september	NOUN
ecj-12574	29	6	2024	2024	NUM
ecj-12574	29	7	.	.	PUNCT
ecj-12574	30	1	this	this	DET
ecj-12574	30	2	work	work	NOUN
ecj-12574	30	3	is	be	AUX
ecj-12574	30	4	licensed	license	VERB
ecj-12574	30	5	under	under	ADP
ecj-12574	30	6	a	a	DET
ecj-12574	30	7	creative	creative	ADJ
ecj-12574	30	8	commons	common	NOUN
ecj-12574	30	9	attribution	attribution	NOUN
ecj-12574	30	10	4.0	4.0	NUM
ecj-12574	30	11	license	license	NOUN
ecj-12574	30	12	(	(	PUNCT
ecj-12574	30	13	by	by	ADP
ecj-12574	30	14	-	-	PUNCT
ecj-12574	30	15	nc	nc	PROPN
ecj-12574	30	16	4.0	4.0	NUM
ecj-12574	30	17	)	)	PUNCT
ecj-12574	30	18	.	.	PUNCT
ecj-12574	31	1	©	©	PROPN
ecj-12574	31	2	copyright	copyright	NOUN
ecj-12574	31	3	:	:	PUNCT
ecj-12574	31	4	the	the	DET
ecj-12574	31	5	author(s	author(s	PROPN
ecj-12574	31	6	)	)	PUNCT
ecj-12574	31	7	,	,	PUNCT
ecj-12574	31	8	2024	2024	NUM
ecj-12574	31	9	licensee	licensee	NOUN
ecj-12574	31	10	pagepress	pagepress	NOUN
ecj-12574	31	11	,	,	PUNCT
ecj-12574	31	12	italy	italy	PROPN
ecj-12574	31	13	emergency	emergency	PROPN
ecj-12574	31	14	care	care	PROPN
ecj-12574	31	15	journal	journal	PROPN
ecj-12574	31	16	2024	2024	NUM
ecj-12574	31	17	;	;	PUNCT
ecj-12574	31	18	20:12574	20:12574	NUM
ecj-12574	31	19	doi:10.4081	doi:10.4081	NOUN
ecj-12574	31	20	/	/	SYM
ecj-12574	31	21	ecj.2024.12574	ecj.2024.12574	PROPN
ecj-12574	31	22	publisher	publisher	NOUN
ecj-12574	31	23	's	's	PART
ecj-12574	31	24	note	note	NOUN
ecj-12574	31	25	:	:	PUNCT
ecj-12574	31	26	all	all	DET
ecj-12574	31	27	claims	claim	NOUN
ecj-12574	31	28	expressed	express	VERB
ecj-12574	31	29	in	in	ADP
ecj-12574	31	30	this	this	DET
ecj-12574	31	31	article	article	NOUN
ecj-12574	31	32	are	be	AUX
ecj-12574	31	33	solely	solely	ADV
ecj-12574	31	34	those	those	PRON
ecj-12574	31	35	of	of	ADP
ecj-12574	31	36	the	the	DET
ecj-12574	31	37	authors	author	NOUN
ecj-12574	31	38	and	and	CCONJ
ecj-12574	31	39	do	do	AUX
ecj-12574	31	40	not	not	PART
ecj-12574	31	41	necessarily	necessarily	ADV
ecj-12574	31	42	represent	represent	VERB
ecj-12574	31	43	those	those	PRON
ecj-12574	31	44	of	of	ADP
ecj-12574	31	45	their	their	PRON
ecj-12574	31	46	affiliated	affiliated	ADJ
ecj-12574	31	47	organizations	organization	NOUN
ecj-12574	31	48	,	,	PUNCT
ecj-12574	31	49	or	or	CCONJ
ecj-12574	31	50	those	those	PRON
ecj-12574	31	51	of	of	ADP
ecj-12574	31	52	the	the	DET
ecj-12574	31	53	publisher	publisher	NOUN
ecj-12574	31	54	,	,	PUNCT
ecj-12574	31	55	the	the	DET
ecj-12574	31	56	editors	editor	NOUN
ecj-12574	31	57	and	and	CCONJ
ecj-12574	31	58	the	the	DET
ecj-12574	31	59	reviewers	reviewer	NOUN
ecj-12574	31	60	.	.	PUNCT
ecj-12574	32	1	any	any	DET
ecj-12574	32	2	product	product	NOUN
ecj-12574	32	3	that	that	PRON
ecj-12574	32	4	may	may	AUX
ecj-12574	32	5	be	be	AUX
ecj-12574	32	6	evaluated	evaluate	VERB
ecj-12574	32	7	in	in	ADP
ecj-12574	32	8	this	this	DET
ecj-12574	32	9	article	article	NOUN
ecj-12574	32	10	or	or	CCONJ
ecj-12574	32	11	claim	claim	NOUN
ecj-12574	32	12	that	that	PRON
ecj-12574	32	13	may	may	AUX
ecj-12574	32	14	be	be	AUX
ecj-12574	32	15	made	make	VERB
ecj-12574	32	16	by	by	ADP
ecj-12574	32	17	its	its	PRON
ecj-12574	32	18	manufacturer	manufacturer	NOUN
ecj-12574	32	19	is	be	AUX
ecj-12574	32	20	not	not	PART
ecj-12574	32	21	guaranteed	guarantee	VERB
ecj-12574	32	22	or	or	CCONJ
ecj-12574	32	23	endorsed	endorse	VERB
ecj-12574	32	24	by	by	ADP
ecj-12574	32	25	the	the	DET
ecj-12574	32	26	publisher	publisher	NOUN
ecj-12574	32	27	.	.	PUNCT
ecj-12574	33	1	non	non	ADJ
ecj-12574	33	2	-co	-co	PROPN
ecj-12574	33	3	mmerc	mmerc	PROPN
ecj-12574	33	4	ial	ial	PROPN
ecj-12574	33	5	us	us	PROPN
ecj-12574	34	1	e	e	NOUN
ecj-12574	34	2	o	o	NOUN
ecj-12574	34	3	nly	nly	ADV
ecj-12574	34	4	the	the	DET
ecj-12574	34	5	terms	term	NOUN
ecj-12574	34	6	“	"	PUNCT
ecj-12574	34	7	citalopram	citalopram	PROPN
ecj-12574	34	8	”	"	PUNCT
ecj-12574	34	9	and	and	CCONJ
ecj-12574	34	10	“	"	PUNCT
ecj-12574	34	11	intoxication	intoxication	NOUN
ecj-12574	34	12	”	"	PUNCT
ecj-12574	34	13	or	or	CCONJ
ecj-12574	34	14	“	"	PUNCT
ecj-12574	34	15	ingestion	ingestion	NOUN
ecj-12574	34	16	”	"	PUNCT
ecj-12574	34	17	and	and	CCONJ
ecj-12574	34	18	or	or	CCONJ
ecj-12574	34	19	“	"	PUNCT
ecj-12574	34	20	pediatric	pediatric	ADJ
ecj-12574	34	21	”	"	PUNCT
ecj-12574	34	22	.	.	PUNCT
ecj-12574	35	1	moreover	moreover	ADV
ecj-12574	35	2	,	,	PUNCT
ecj-12574	35	3	the	the	DET
ecj-12574	35	4	reference	reference	NOUN
ecj-12574	35	5	lists	list	NOUN
ecj-12574	35	6	of	of	ADP
ecj-12574	35	7	eligible	eligible	ADJ
ecj-12574	35	8	articles	article	NOUN
ecj-12574	35	9	were	be	AUX
ecj-12574	35	10	screened	screen	VERB
ecj-12574	35	11	to	to	PART
ecj-12574	35	12	identify	identify	VERB
ecj-12574	35	13	any	any	DET
ecj-12574	35	14	further	further	ADJ
ecj-12574	35	15	relevant	relevant	ADJ
ecj-12574	35	16	articles	article	NOUN
ecj-12574	35	17	.	.	PUNCT
ecj-12574	36	1	we	we	PRON
ecj-12574	36	2	manually	manually	ADV
ecj-12574	36	3	selected	select	VERB
ecj-12574	36	4	articles	article	NOUN
ecj-12574	36	5	related	relate	VERB
ecj-12574	36	6	to	to	ADP
ecj-12574	36	7	paediatric	paediatric	ADJ
ecj-12574	36	8	patients	patient	NOUN
ecj-12574	36	9	(	(	PUNCT
ecj-12574	36	10	≤18	≤18	ADJ
ecj-12574	36	11	years	year	NOUN
ecj-12574	36	12	old	old	ADJ
ecj-12574	36	13	)	)	PUNCT
ecj-12574	36	14	.	.	PUNCT
ecj-12574	37	1	we	we	PRON
ecj-12574	37	2	excluded	exclude	VERB
ecj-12574	37	3	articles	article	NOUN
ecj-12574	37	4	without	without	ADP
ecj-12574	37	5	patient	patient	ADJ
ecj-12574	37	6	clinical	clinical	ADJ
ecj-12574	37	7	descriptions	description	NOUN
ecj-12574	37	8	and/or	and/or	CCONJ
ecj-12574	37	9	with	with	ADP
ecj-12574	37	10	multiple	multiple	ADJ
ecj-12574	37	11	intoxications	intoxication	NOUN
ecj-12574	37	12	.	.	PUNCT
ecj-12574	38	1	finally	finally	ADV
ecj-12574	38	2	,	,	PUNCT
ecj-12574	38	3	we	we	PRON
ecj-12574	38	4	limited	limit	VERB
ecj-12574	38	5	our	our	PRON
ecj-12574	38	6	search	search	NOUN
ecj-12574	38	7	to	to	ADP
ecj-12574	38	8	original	original	ADJ
ecj-12574	38	9	studies	study	NOUN
ecj-12574	38	10	published	publish	VERB
ecj-12574	38	11	in	in	ADP
ecj-12574	38	12	the	the	DET
ecj-12574	38	13	english	english	ADJ
ecj-12574	38	14	and	and	CCONJ
ecj-12574	38	15	french	french	ADJ
ecj-12574	38	16	languages	language	NOUN
ecj-12574	38	17	.	.	PUNCT
ecj-12574	39	1	case	case	NOUN
ecj-12574	39	2	report	report	NOUN
ecj-12574	39	3	here	here	ADV
ecj-12574	39	4	we	we	PRON
ecj-12574	39	5	describe	describe	VERB
ecj-12574	39	6	a	a	DET
ecj-12574	39	7	12	12	NUM
ecj-12574	39	8	months	month	NOUN
ecj-12574	39	9	female	female	ADJ
ecj-12574	39	10	child	child	NOUN
ecj-12574	39	11	(	(	PUNCT
ecj-12574	39	12	10	10	NUM
ecj-12574	39	13	kg	kg	NOUN
ecj-12574	39	14	)	)	PUNCT
ecj-12574	39	15	,	,	PUNCT
ecj-12574	39	16	with	with	ADP
ecj-12574	39	17	adequate	adequate	ADJ
ecj-12574	39	18	psychomotor	psychomotor	NOUN
ecj-12574	39	19	development	development	NOUN
ecj-12574	39	20	,	,	PUNCT
ecj-12574	39	21	born	bear	VERB
ecj-12574	39	22	from	from	ADP
ecj-12574	39	23	blood	blood	NOUN
ecj-12574	39	24	relatives	relative	NOUN
ecj-12574	39	25	parents	parent	NOUN
ecj-12574	39	26	(	(	PUNCT
ecj-12574	39	27	cousins	cousin	NOUN
ecj-12574	39	28	)	)	PUNCT
ecj-12574	39	29	originating	originate	VERB
ecj-12574	39	30	from	from	ADP
ecj-12574	39	31	africa	africa	PROPN
ecj-12574	39	32	,	,	PUNCT
ecj-12574	39	33	with	with	ADP
ecj-12574	39	34	an	an	DET
ecj-12574	39	35	uneventful	uneventful	ADJ
ecj-12574	39	36	birth	birth	NOUN
ecj-12574	39	37	.	.	PUNCT
ecj-12574	40	1	the	the	DET
ecj-12574	40	2	baby	baby	NOUN
ecj-12574	40	3	was	be	AUX
ecj-12574	40	4	brought	bring	VERB
ecj-12574	40	5	to	to	ADP
ecj-12574	40	6	our	our	PRON
ecj-12574	40	7	attention	attention	NOUN
ecj-12574	40	8	at	at	ADP
ecj-12574	40	9	the	the	DET
ecj-12574	40	10	age	age	NOUN
ecj-12574	40	11	of	of	ADP
ecj-12574	40	12	12	12	NUM
ecj-12574	40	13	months	month	NOUN
ecj-12574	40	14	in	in	ADP
ecj-12574	40	15	the	the	DET
ecj-12574	40	16	emergency	emergency	NOUN
ecj-12574	40	17	department	department	NOUN
ecj-12574	40	18	(	(	PUNCT
ecj-12574	40	19	ed	ed	NOUN
ecj-12574	40	20	)	)	PUNCT
ecj-12574	40	21	because	because	SCONJ
ecj-12574	40	22	of	of	ADP
ecj-12574	40	23	a	a	DET
ecj-12574	40	24	first	first	ADJ
ecj-12574	40	25	seizure	seizure	NOUN
ecj-12574	40	26	without	without	ADP
ecj-12574	40	27	fever	fever	NOUN
ecj-12574	40	28	.	.	PUNCT
ecj-12574	41	1	the	the	DET
ecj-12574	41	2	mother	mother	NOUN
ecj-12574	41	3	referred	refer	VERB
ecj-12574	41	4	at	at	ADP
ecj-12574	41	5	home	home	NOUN
ecj-12574	41	6	an	an	DET
ecj-12574	41	7	episode	episode	NOUN
ecj-12574	41	8	lasting	last	VERB
ecj-12574	41	9	4	4	NUM
ecj-12574	41	10	-	-	SYM
ecj-12574	41	11	5	5	NUM
ecj-12574	41	12	minutes	minute	NOUN
ecj-12574	41	13	,	,	PUNCT
ecj-12574	41	14	characterized	characterize	VERB
ecj-12574	41	15	by	by	ADP
ecj-12574	41	16	ocular	ocular	ADJ
ecj-12574	41	17	revulsion	revulsion	NOUN
ecj-12574	41	18	and	and	CCONJ
ecj-12574	41	19	four	four	NUM
ecj-12574	41	20	arms	arm	NOUN
ecj-12574	41	21	tonic	tonic	NOUN
ecj-12574	41	22	-	-	PUNCT
ecj-12574	41	23	clonic	clonic	NOUN
ecj-12574	41	24	movements	movement	NOUN
ecj-12574	41	25	with	with	ADP
ecj-12574	41	26	spontaneous	spontaneous	ADJ
ecj-12574	41	27	resolution	resolution	NOUN
ecj-12574	41	28	.	.	PUNCT
ecj-12574	42	1	at	at	ADP
ecj-12574	42	2	the	the	DET
ecj-12574	42	3	ed	ed	NOUN
ecj-12574	42	4	,	,	PUNCT
ecj-12574	42	5	the	the	DET
ecj-12574	42	6	baby	baby	NOUN
ecj-12574	42	7	was	be	AUX
ecj-12574	42	8	apyretic	apyretic	ADJ
ecj-12574	42	9	and	and	CCONJ
ecj-12574	42	10	she	she	PRON
ecj-12574	42	11	presented	present	VERB
ecj-12574	42	12	a	a	DET
ecj-12574	42	13	second	second	ADJ
ecj-12574	42	14	similar	similar	ADJ
ecj-12574	42	15	paroxysmal	paroxysmal	ADJ
ecj-12574	42	16	episode	episode	NOUN
ecj-12574	42	17	.	.	PUNCT
ecj-12574	43	1	she	she	PRON
ecj-12574	43	2	was	be	AUX
ecj-12574	43	3	submitted	submit	VERB
ecj-12574	43	4	to	to	PART
ecj-12574	43	5	complete	complete	VERB
ecj-12574	43	6	blood	blood	NOUN
ecj-12574	43	7	chemistry	chemistry	NOUN
ecj-12574	43	8	tests	test	NOUN
ecj-12574	43	9	(	(	PUNCT
ecj-12574	43	10	blood	blood	NOUN
ecj-12574	43	11	gas	gas	NOUN
ecj-12574	43	12	analysis	analysis	NOUN
ecj-12574	43	13	,	,	PUNCT
ecj-12574	43	14	electrolyte	electrolyte	ADJ
ecj-12574	43	15	,	,	PUNCT
ecj-12574	43	16	carboxyhemoglobin	carboxyhemoglobin	NOUN
ecj-12574	43	17	dosage	dosage	NOUN
ecj-12574	43	18	,	,	PUNCT
ecj-12574	43	19	ethanol	ethanol	NOUN
ecj-12574	43	20	and	and	CCONJ
ecj-12574	43	21	substance	substance	NOUN
ecj-12574	43	22	abuse	abuse	NOUN
ecj-12574	43	23	)	)	PUNCT
ecj-12574	43	24	,	,	PUNCT
ecj-12574	43	25	which	which	PRON
ecj-12574	43	26	resulted	result	VERB
ecj-12574	43	27	negative	negative	ADJ
ecj-12574	43	28	.	.	PUNCT
ecj-12574	44	1	cardiological	cardiological	ADJ
ecj-12574	44	2	evaluation	evaluation	NOUN
ecj-12574	44	3	did	do	AUX
ecj-12574	44	4	not	not	PART
ecj-12574	44	5	reveal	reveal	VERB
ecj-12574	44	6	any	any	DET
ecj-12574	44	7	involvement	involvement	NOUN
ecj-12574	44	8	:	:	PUNCT
ecj-12574	44	9	heart	heart	NOUN
ecj-12574	44	10	rate	rate	NOUN
ecj-12574	44	11	and	and	CCONJ
ecj-12574	44	12	pressure	pressure	NOUN
ecj-12574	44	13	remained	remain	VERB
ecj-12574	44	14	regular	regular	ADJ
ecj-12574	44	15	for	for	ADP
ecj-12574	44	16	the	the	DET
ecj-12574	44	17	entire	entire	ADJ
ecj-12574	44	18	hospitalization	hospitalization	NOUN
ecj-12574	44	19	.	.	PUNCT
ecj-12574	45	1	in	in	ADP
ecj-12574	45	2	that	that	DET
ecj-12574	45	3	context	context	NOUN
ecj-12574	45	4	,	,	PUNCT
ecj-12574	45	5	the	the	DET
ecj-12574	45	6	mother	mother	NOUN
ecj-12574	45	7	appeared	appear	VERB
ecj-12574	45	8	globally	globally	ADV
ecj-12574	45	9	numb	numb	ADJ
ecj-12574	45	10	to	to	ADP
ecj-12574	45	11	clinicians	clinician	NOUN
ecj-12574	45	12	.	.	PUNCT
ecj-12574	46	1	she	she	PRON
ecj-12574	46	2	referred	refer	VERB
ecj-12574	46	3	to	to	ADP
ecj-12574	46	4	a	a	DET
ecj-12574	46	5	personal	personal	ADJ
ecj-12574	46	6	recent	recent	ADJ
ecj-12574	46	7	history	history	NOUN
ecj-12574	46	8	of	of	ADP
ecj-12574	46	9	psychogenic	psychogenic	ADJ
ecj-12574	46	10	nonepileptic	nonepileptic	ADJ
ecj-12574	46	11	seizures	seizure	NOUN
ecj-12574	46	12	,	,	PUNCT
ecj-12574	46	13	treated	treat	VERB
ecj-12574	46	14	with	with	ADP
ecj-12574	46	15	citalopram	citalopram	PROPN
ecj-12574	46	16	and	and	CCONJ
ecj-12574	46	17	delorazepam	delorazepam	PROPN
ecj-12574	46	18	(	(	PUNCT
ecj-12574	46	19	the	the	DET
ecj-12574	46	20	child	child	NOUN
ecj-12574	46	21	was	be	AUX
ecj-12574	46	22	not	not	PART
ecj-12574	46	23	breastfed	breastfe	VERB
ecj-12574	46	24	)	)	PUNCT
ecj-12574	46	25	.	.	PUNCT
ecj-12574	47	1	child	child	NOUN
ecj-12574	47	2	hospitalization	hospitalization	NOUN
ecj-12574	47	3	was	be	AUX
ecj-12574	47	4	required	require	VERB
ecj-12574	47	5	and	and	CCONJ
ecj-12574	47	6	she	she	PRON
ecj-12574	47	7	was	be	AUX
ecj-12574	47	8	submitted	submit	VERB
ecj-12574	47	9	to	to	ADP
ecj-12574	47	10	sleep	sleep	NOUN
ecj-12574	47	11	-	-	PUNCT
ecj-12574	47	12	awake	awake	ADJ
ecj-12574	47	13	eeg	eeg	NOUN
ecj-12574	47	14	:	:	PUNCT
ecj-12574	47	15	negative	negative	ADJ
ecj-12574	47	16	(	(	PUNCT
ecj-12574	47	17	figure	figure	NOUN
ecj-12574	47	18	2a	2a	NUM
ecj-12574	47	19	)	)	PUNCT
ecj-12574	47	20	.	.	PUNCT
ecj-12574	48	1	the	the	DET
ecj-12574	48	2	brain	brain	NOUN
ecj-12574	48	3	mri	mri	NOUN
ecj-12574	48	4	was	be	AUX
ecj-12574	48	5	normal	normal	ADJ
ecj-12574	48	6	(	(	PUNCT
ecj-12574	48	7	figure	figure	NOUN
ecj-12574	48	8	3a	3a	NUM
ecj-12574	48	9	)	)	PUNCT
ecj-12574	48	10	.	.	PUNCT
ecj-12574	49	1	during	during	ADP
ecj-12574	49	2	the	the	DET
ecj-12574	49	3	second	second	ADJ
ecj-12574	49	4	hospitalization	hospitalization	NOUN
ecj-12574	49	5	day	day	NOUN
ecj-12574	49	6	,	,	PUNCT
ecj-12574	49	7	she	she	PRON
ecj-12574	49	8	displayed	display	VERB
ecj-12574	49	9	fever	fever	NOUN
ecj-12574	49	10	and	and	CCONJ
ecj-12574	49	11	three	three	NUM
ecj-12574	49	12	paroxysmal	paroxysmal	ADJ
ecj-12574	49	13	episodes	episode	NOUN
ecj-12574	49	14	with	with	ADP
ecj-12574	49	15	desaturation	desaturation	NOUN
ecj-12574	49	16	,	,	PUNCT
ecj-12574	49	17	loss	loss	NOUN
ecj-12574	49	18	of	of	ADP
ecj-12574	49	19	consciousness	consciousness	NOUN
ecj-12574	49	20	,	,	PUNCT
ecj-12574	49	21	leg	leg	NOUN
ecj-12574	49	22	hypertonia	hypertonia	NOUN
ecj-12574	49	23	,	,	PUNCT
ecj-12574	49	24	and	and	CCONJ
ecj-12574	49	25	clonic	clonic	ADJ
ecj-12574	49	26	movements	movement	NOUN
ecj-12574	49	27	of	of	ADP
ecj-12574	49	28	the	the	DET
ecj-12574	49	29	left	left	ADJ
ecj-12574	49	30	arm	arm	NOUN
ecj-12574	49	31	,	,	PUNCT
ecj-12574	49	32	treated	treat	VERB
ecj-12574	49	33	with	with	ADP
ecj-12574	49	34	midazolam	midazolam	PROPN
ecj-12574	49	35	iv	iv	ADP
ecj-12574	49	36	and	and	CCONJ
ecj-12574	49	37	levetiracetam	levetiracetam	NOUN
ecj-12574	49	38	iv	iv	NUM
ecj-12574	49	39	bolus	bolus	NOUN
ecj-12574	49	40	with	with	ADP
ecj-12574	49	41	partial	partial	ADJ
ecj-12574	49	42	seizures	seizure	NOUN
ecj-12574	49	43	control	control	NOUN
ecj-12574	49	44	(	(	PUNCT
ecj-12574	49	45	figure	figure	NOUN
ecj-12574	49	46	2b	2b	NOUN
ecj-12574	49	47	)	)	PUNCT
ecj-12574	49	48	.	.	PUNCT
ecj-12574	50	1	in	in	ADP
ecj-12574	50	2	the	the	DET
ecj-12574	50	3	following	following	ADJ
ecj-12574	50	4	days	day	NOUN
ecj-12574	50	5	,	,	PUNCT
ecj-12574	50	6	the	the	DET
ecj-12574	50	7	baby	baby	NOUN
ecj-12574	50	8	still	still	ADV
ecj-12574	50	9	displayed	display	VERB
ecj-12574	50	10	frequent	frequent	ADJ
ecj-12574	50	11	occipital	occipital	ADJ
ecj-12574	50	12	focal	focal	ADJ
ecj-12574	50	13	seizures	seizure	NOUN
ecj-12574	50	14	(	(	PUNCT
ecj-12574	50	15	figure	figure	NOUN
ecj-12574	50	16	2c	2c	NUM
ecj-12574	50	17	)	)	PUNCT
ecj-12574	50	18	and	and	CCONJ
ecj-12574	50	19	she	she	PRON
ecj-12574	50	20	started	start	VERB
ecj-12574	50	21	to	to	PART
ecj-12574	50	22	display	display	VERB
ecj-12574	50	23	a	a	DET
ecj-12574	50	24	global	global	ADJ
ecj-12574	50	25	neurological	neurological	ADJ
ecj-12574	50	26	regression	regression	NOUN
ecj-12574	50	27	,	,	PUNCT
ecj-12574	50	28	with	with	ADP
ecj-12574	50	29	hypotonia	hypotonia	NOUN
ecj-12574	50	30	,	,	PUNCT
ecj-12574	50	31	less	less	ADJ
ecj-12574	50	32	of	of	ADP
ecj-12574	50	33	head	head	NOUN
ecj-12574	50	34	and	and	CCONJ
ecj-12574	50	35	trunk	trunk	NOUN
ecj-12574	50	36	control	control	NOUN
ecj-12574	50	37	,	,	PUNCT
ecj-12574	50	38	right	right	ADJ
ecj-12574	50	39	hemiparesis	hemiparesis	NOUN
ecj-12574	50	40	and	and	CCONJ
ecj-12574	50	41	a	a	DET
ecj-12574	50	42	progressive	progressive	ADJ
ecj-12574	50	43	wakefulness	wakefulness	NOUN
ecj-12574	50	44	reduction	reduction	NOUN
ecj-12574	50	45	associated	associate	VERB
ecj-12574	50	46	to	to	ADP
ecj-12574	50	47	visual	visual	ADJ
ecj-12574	50	48	impairment	impairment	NOUN
ecj-12574	50	49	and	and	CCONJ
ecj-12574	50	50	progressive	progressive	ADJ
ecj-12574	50	51	blindness	blindness	NOUN
ecj-12574	50	52	.	.	PUNCT
ecj-12574	51	1	phenobarbital	phenobarbital	ADJ
ecj-12574	51	2	infusion	infusion	NOUN
ecj-12574	51	3	was	be	AUX
ecj-12574	51	4	started	start	VERB
ecj-12574	51	5	with	with	ADP
ecj-12574	51	6	seizures	seizure	NOUN
ecj-12574	51	7	resolution	resolution	NOUN
ecj-12574	51	8	,	,	PUNCT
ecj-12574	51	9	associated	associate	VERB
ecj-12574	51	10	with	with	ADP
ecj-12574	51	11	ceftriaxone	ceftriaxone	PROPN
ecj-12574	51	12	,	,	PUNCT
ecj-12574	51	13	acyclovir	acyclovir	PROPN
ecj-12574	51	14	and	and	CCONJ
ecj-12574	51	15	dexamethasone	dexamethasone	NOUN
ecj-12574	51	16	in	in	ADP
ecj-12574	51	17	order	order	NOUN
ecj-12574	51	18	to	to	PART
ecj-12574	51	19	treat	treat	VERB
ecj-12574	51	20	a	a	DET
ecj-12574	51	21	possible	possible	ADJ
ecj-12574	51	22	infectious	infectious	ADJ
ecj-12574	51	23	pathogenesis	pathogenesis	NOUN
ecj-12574	51	24	.	.	PUNCT
ecj-12574	52	1	lumbar	lumbar	NOUN
ecj-12574	52	2	puncture	puncture	NOUN
ecj-12574	52	3	with	with	ADP
ecj-12574	52	4	immunological	immunological	ADJ
ecj-12574	52	5	screening	screening	NOUN
ecj-12574	52	6	,	,	PUNCT
ecj-12574	52	7	link	link	VERB
ecj-12574	52	8	index	index	NOUN
ecj-12574	52	9	and	and	CCONJ
ecj-12574	52	10	cultural	cultural	ADJ
ecj-12574	52	11	exams	exam	NOUN
ecj-12574	52	12	was	be	AUX
ecj-12574	52	13	negative	negative	ADJ
ecj-12574	52	14	.	.	PUNCT
ecj-12574	53	1	metabolic	metabolic	NOUN
ecj-12574	53	2	discharges	discharge	NOUN
ecj-12574	53	3	(	(	PUNCT
ecj-12574	53	4	plasmatic	plasmatic	ADJ
ecj-12574	53	5	amino	amino	NOUN
ecj-12574	53	6	acid	acid	NOUN
ecj-12574	53	7	,	,	PUNCT
ecj-12574	53	8	plasmatic	plasmatic	NOUN
ecj-12574	53	9	acylcarnitines	acylcarnitine	NOUN
ecj-12574	53	10	,	,	PUNCT
ecj-12574	53	11	urinary	urinary	ADJ
ecj-12574	53	12	organic	organic	ADJ
ecj-12574	53	13	acid	acid	NOUN
ecj-12574	53	14	)	)	PUNCT
ecj-12574	53	15	were	be	AUX
ecj-12574	53	16	excluded	exclude	VERB
ecj-12574	53	17	.	.	PUNCT
ecj-12574	54	1	epilepsy	epilepsy	ADJ
ecj-12574	54	2	gene	gene	NOUN
ecj-12574	54	3	panels	panel	NOUN
ecj-12574	54	4	,	,	PUNCT
ecj-12574	54	5	and	and	CCONJ
ecj-12574	54	6	mitochondrial	mitochondrial	ADJ
ecj-12574	54	7	gene	gene	NOUN
ecj-12574	54	8	panels	panel	NOUN
ecj-12574	54	9	(	(	PUNCT
ecj-12574	54	10	mitochondrial	mitochondrial	ADJ
ecj-12574	54	11	encephalomyopathy	encephalomyopathy	ADJ
ecj-12574	54	12	,	,	PUNCT
ecj-12574	54	13	lactic	lactic	ADJ
ecj-12574	54	14	acidosis	acidosis	NOUN
ecj-12574	54	15	and	and	CCONJ
ecj-12574	54	16	strokelike	strokelike	ADJ
ecj-12574	54	17	episodes	episode	NOUN
ecj-12574	54	18	(	(	PUNCT
ecj-12574	54	19	melas	mela	NOUN
ecj-12574	54	20	)	)	PUNCT
ecj-12574	54	21	,	,	PUNCT
ecj-12574	54	22	maternally	maternally	ADV
ecj-12574	54	23	inherited	inherit	VERB
ecj-12574	54	24	diabetes	diabetes	NOUN
ecj-12574	54	25	mellitus	mellitus	NOUN
ecj-12574	54	26	and	and	CCONJ
ecj-12574	54	27	deafness	deafness	NOUN
ecj-12574	54	28	(	(	PUNCT
ecj-12574	54	29	midd	midd	NOUN
ecj-12574	54	30	)	)	PUNCT
ecj-12574	54	31	were	be	AUX
ecj-12574	54	32	negative	negative	ADJ
ecj-12574	54	33	.	.	PUNCT
ecj-12574	55	1	in	in	ADP
ecj-12574	55	2	the	the	DET
ecj-12574	55	3	following	follow	VERB
ecj-12574	55	4	days	day	NOUN
ecj-12574	55	5	the	the	DET
ecj-12574	55	6	baby	baby	NOUN
ecj-12574	55	7	presented	present	VERB
ecj-12574	55	8	an	an	DET
ecj-12574	55	9	ulterior	ulterior	ADJ
ecj-12574	55	10	global	global	ADJ
ecj-12574	55	11	worsening	worsen	VERB
ecj-12574	55	12	with	with	ADP
ecj-12574	55	13	persistent	persistent	ADJ
ecj-12574	55	14	seizures	seizure	NOUN
ecj-12574	55	15	,	,	PUNCT
ecj-12574	55	16	hypotonia	hypotonia	NOUN
ecj-12574	55	17	,	,	PUNCT
ecj-12574	55	18	inconsolable	inconsolable	ADJ
ecj-12574	55	19	crying	crying	NOUN
ecj-12574	55	20	and	and	CCONJ
ecj-12574	55	21	irritability	irritability	NOUN
ecj-12574	55	22	.	.	PUNCT
ecj-12574	56	1	eeg	eeg	NOUN
ecj-12574	56	2	displayed	display	VERB
ecj-12574	56	3	concomitant	concomitant	ADJ
ecj-12574	56	4	left	leave	VERB
ecj-12574	56	5	occipital	occipital	ADJ
ecj-12574	56	6	epileptic	epileptic	ADJ
ecj-12574	56	7	discharges	discharge	NOUN
ecj-12574	56	8	(	(	PUNCT
ecj-12574	56	9	figure	figure	NOUN
ecj-12574	56	10	2d	2d	NOUN
ecj-12574	56	11	)	)	PUNCT
ecj-12574	56	12	.	.	PUNCT
ecj-12574	57	1	due	due	ADP
ecj-12574	57	2	to	to	ADP
ecj-12574	57	3	the	the	DET
ecj-12574	57	4	progressive	progressive	ADJ
ecj-12574	57	5	clinical	clinical	ADJ
ecj-12574	57	6	deterioration	deterioration	NOUN
ecj-12574	57	7	,	,	PUNCT
ecj-12574	57	8	the	the	DET
ecj-12574	57	9	baby	baby	NOUN
ecj-12574	57	10	was	be	AUX
ecj-12574	57	11	conducted	conduct	VERB
ecj-12574	57	12	to	to	ADP
ecj-12574	57	13	the	the	DET
ecj-12574	57	14	intensive	intensive	ADJ
ecj-12574	57	15	care	care	NOUN
ecj-12574	57	16	unit	unit	NOUN
ecj-12574	57	17	where	where	SCONJ
ecj-12574	57	18	she	she	PRON
ecj-12574	57	19	remained	remain	VERB
ecj-12574	57	20	persistently	persistently	ADV
ecj-12574	57	21	lethargic	lethargic	ADJ
ecj-12574	57	22	but	but	CCONJ
ecj-12574	57	23	autonomously	autonomously	ADV
ecj-12574	57	24	breathing	breathe	VERB
ecj-12574	57	25	.	.	PUNCT
ecj-12574	58	1	in	in	ADP
ecj-12574	58	2	the	the	DET
ecj-12574	58	3	meanwhile	meanwhile	NOUN
ecj-12574	58	4	,	,	PUNCT
ecj-12574	58	5	the	the	DET
ecj-12574	58	6	mother	mother	NOUN
ecj-12574	58	7	was	be	AUX
ecj-12574	58	8	found	find	VERB
ecj-12574	58	9	persistently	persistently	ADV
ecj-12574	58	10	drowsy	drowsy	NOUN
ecj-12574	58	11	.	.	PUNCT
ecj-12574	59	1	suspecting	suspect	VERB
ecj-12574	59	2	a	a	DET
ecj-12574	59	3	voluntary	voluntary	ADJ
ecj-12574	59	4	child	child	NOUN
ecj-12574	59	5	intoxication	intoxication	NOUN
ecj-12574	59	6	,	,	PUNCT
ecj-12574	59	7	it	it	PRON
ecj-12574	59	8	was	be	AUX
ecj-12574	59	9	hence	hence	ADV
ecj-12574	59	10	required	require	VERB
ecj-12574	59	11	a	a	DET
ecj-12574	59	12	baby	baby	NOUN
ecj-12574	59	13	plasmatic	plasmatic	NOUN
ecj-12574	59	14	dosage	dosage	NOUN
ecj-12574	59	15	of	of	ADP
ecj-12574	59	16	citalopram	citalopram	PROPN
ecj-12574	59	17	on	on	ADP
ecj-12574	59	18	the	the	DET
ecj-12574	59	19	blood	blood	NOUN
ecj-12574	59	20	sample	sample	NOUN
ecj-12574	59	21	executed	execute	VERB
ecj-12574	59	22	in	in	ADP
ecj-12574	59	23	the	the	DET
ecj-12574	59	24	ed	ed	NOUN
ecj-12574	59	25	with	with	ADP
ecj-12574	59	26	confirmation	confirmation	NOUN
ecj-12574	59	27	of	of	ADP
ecj-12574	59	28	plasmatic	plasmatic	ADJ
ecj-12574	59	29	concentration	concentration	NOUN
ecj-12574	59	30	equal	equal	ADJ
ecj-12574	59	31	to	to	ADP
ecj-12574	59	32	3225	3225	NUM
ecj-12574	59	33	ng	ng	PROPN
ecj-12574	59	34	/	/	SYM
ecj-12574	59	35	ml	ml	PROPN
ecj-12574	59	36	(	(	PUNCT
ecj-12574	59	37	therapeutic	therapeutic	ADJ
ecj-12574	59	38	interval	interval	NOUN
ecj-12574	59	39	50	50	NUM
ecj-12574	59	40	-	-	SYM
ecj-12574	59	41	110	110	NUM
ecj-12574	59	42	ng	ng	PROPN
ecj-12574	59	43	/	/	SYM
ecj-12574	59	44	ml	ml	PROPN
ecj-12574	59	45	)	)	PUNCT
ecj-12574	59	46	,	,	PUNCT
ecj-12574	59	47	125	125	NUM
ecj-12574	59	48	ng	ng	NOUN
ecj-12574	59	49	/	/	SYM
ecj-12574	59	50	ml	ml	NOUN
ecj-12574	59	51	after	after	ADP
ecj-12574	59	52	4	4	NUM
ecj-12574	59	53	days	day	NOUN
ecj-12574	59	54	,	,	PUNCT
ecj-12574	59	55	25ng	25ng	NOUN
ecj-12574	59	56	/	/	SYM
ecj-12574	59	57	ml	ml	ADV
ecj-12574	59	58	at	at	ADP
ecj-12574	59	59	day	day	NOUN
ecj-12574	59	60	8	8	NUM
ecj-12574	59	61	.	.	PUNCT
ecj-12574	60	1	we	we	PRON
ecj-12574	60	2	estimated	estimate	VERB
ecj-12574	60	3	an	an	DET
ecj-12574	60	4	oral	oral	ADJ
ecj-12574	60	5	assumption	assumption	NOUN
ecj-12574	60	6	equal	equal	ADJ
ecj-12574	60	7	to	to	ADP
ecj-12574	60	8	450	450	NUM
ecj-12574	60	9	mg	mg	NOUN
ecj-12574	60	10	(	(	PUNCT
ecj-12574	60	11	45	45	NUM
ecj-12574	60	12	mg	mg	PROPN
ecj-12574	60	13	/	/	SYM
ecj-12574	60	14	kg	kg	PROPN
ecj-12574	60	15	)	)	PUNCT
ecj-12574	60	16	.	.	PUNCT
ecj-12574	61	1	the	the	DET
ecj-12574	61	2	baby	baby	NOUN
ecj-12574	61	3	was	be	AUX
ecj-12574	61	4	immediately	immediately	ADV
ecj-12574	61	5	separated	separate	VERB
ecj-12574	61	6	from	from	ADP
ecj-12574	61	7	the	the	DET
ecj-12574	61	8	mother	mother	NOUN
ecj-12574	61	9	,	,	PUNCT
ecj-12574	61	10	according	accord	VERB
ecj-12574	61	11	to	to	ADP
ecj-12574	61	12	judicial	judicial	ADJ
ecj-12574	61	13	authority	authority	NOUN
ecj-12574	61	14	indications	indication	NOUN
ecj-12574	61	15	.	.	PUNCT
ecj-12574	62	1	after	after	ADP
ecj-12574	62	2	these	these	DET
ecj-12574	62	3	results	result	NOUN
ecj-12574	62	4	(	(	PUNCT
ecj-12574	62	5	5th	5th	ADJ
ecj-12574	62	6	hospitalization	hospitalization	NOUN
ecj-12574	62	7	day	day	NOUN
ecj-12574	62	8	)	)	PUNCT
ecj-12574	62	9	,	,	PUNCT
ecj-12574	62	10	we	we	PRON
ecj-12574	62	11	started	start	VERB
ecj-12574	62	12	therapy	therapy	NOUN
ecj-12574	62	13	with	with	ADP
ecj-12574	62	14	cyproheptadine	cyproheptadine	NOUN
ecj-12574	62	15	6	6	NUM
ecj-12574	62	16	mg	mg	NUM
ecj-12574	62	17	/	/	SYM
ecj-12574	62	18	day	day	NOUN
ecj-12574	62	19	(	(	PUNCT
ecj-12574	62	20	0,6	0,6	NUM
ecj-12574	62	21	mg	mg	PROPN
ecj-12574	62	22	/	/	SYM
ecj-12574	62	23	kg	kg	PROPN
ecj-12574	62	24	/	/	SYM
ecj-12574	62	25	day	day	NOUN
ecj-12574	62	26	)	)	PUNCT
ecj-12574	62	27	per	per	ADP
ecj-12574	62	28	nasogastric	nasogastric	ADJ
ecj-12574	62	29	tube	tube	NOUN
ecj-12574	62	30	with	with	ADP
ecj-12574	62	31	progressive	progressive	ADJ
ecj-12574	62	32	seizures	seizure	NOUN
ecj-12574	62	33	resolution	resolution	NOUN
ecj-12574	62	34	and	and	CCONJ
ecj-12574	62	35	consequent	consequent	ADJ
ecj-12574	62	36	dosage	dosage	NOUN
ecj-12574	62	37	reduction	reduction	NOUN
ecj-12574	62	38	in	in	ADP
ecj-12574	62	39	5	5	NUM
ecj-12574	62	40	days	day	NOUN
ecj-12574	62	41	.	.	PUNCT
ecj-12574	63	1	the	the	DET
ecj-12574	63	2	baby	baby	NOUN
ecj-12574	63	3	displayed	display	VERB
ecj-12574	63	4	a	a	DET
ecj-12574	63	5	progressive	progressive	ADJ
ecj-12574	63	6	global	global	ADJ
ecj-12574	63	7	improvement	improvement	NOUN
ecj-12574	63	8	with	with	ADP
ecj-12574	63	9	case	case	NOUN
ecj-12574	63	10	report	report	NOUN
ecj-12574	63	11	[	[	X
ecj-12574	63	12	page	page	NOUN
ecj-12574	63	13	66	66	NUM
ecj-12574	63	14	]	]	PUNCT
ecj-12574	64	1	[	[	X
ecj-12574	64	2	emergency	emergency	NOUN
ecj-12574	64	3	care	care	NOUN
ecj-12574	64	4	journal	journal	PROPN
ecj-12574	64	5	2024	2024	NUM
ecj-12574	64	6	;	;	PUNCT
ecj-12574	64	7	20:12574	20:12574	NUM
ecj-12574	64	8	]	]	PUNCT
ecj-12574	64	9	figure	figure	NOUN
ecj-12574	64	10	1	1	NUM
ecj-12574	64	11	.	.	PUNCT
ecj-12574	65	1	prisma	prisma	PROPN
ecj-12574	65	2	2020	2020	NUM
ecj-12574	65	3	flow	flow	NOUN
ecj-12574	65	4	diagram	diagram	NOUN
ecj-12574	65	5	of	of	ADP
ecj-12574	65	6	study	study	NOUN
ecj-12574	65	7	selection	selection	NOUN
ecj-12574	65	8	about	about	ADP
ecj-12574	65	9	citalopram	citalopram	NOUN
ecj-12574	65	10	intoxications	intoxication	NOUN
ecj-12574	65	11	in	in	ADP
ecj-12574	65	12	pediatric	pediatric	ADJ
ecj-12574	65	13	patients	patient	NOUN
ecj-12574	65	14	(	(	PUNCT
ecj-12574	65	15	0	0	NUM
ecj-12574	65	16	-	-	SYM
ecj-12574	65	17	18	18	NUM
ecj-12574	65	18	y	y	NOUN
ecj-12574	65	19	)	)	PUNCT
ecj-12574	65	20	.	.	PUNCT
ecj-12574	66	1	non	non	ADJ
ecj-12574	67	1	-co	-co	PROPN
ecj-12574	67	2	mmerc	mmerc	PROPN
ecj-12574	67	3	ial	ial	PROPN
ecj-12574	67	4	us	us	PROPN
ecj-12574	67	5	e	e	NOUN
ecj-12574	67	6	o	o	NOUN
ecj-12574	67	7	nly	nly	ADV
ecj-12574	67	8	reduction	reduction	NOUN
ecj-12574	67	9	of	of	ADP
ecj-12574	67	10	somnolence	somnolence	NOUN
ecj-12574	67	11	,	,	PUNCT
ecj-12574	67	12	staying	stay	VERB
ecj-12574	67	13	seated	seat	VERB
ecj-12574	67	14	alone	alone	ADJ
ecj-12574	67	15	capability	capability	NOUN
ecj-12574	67	16	recovery	recovery	NOUN
ecj-12574	67	17	and	and	CCONJ
ecj-12574	67	18	right	right	ADJ
ecj-12574	67	19	hemiparesis	hemiparesis	NOUN
ecj-12574	67	20	resolution	resolution	NOUN
ecj-12574	67	21	.	.	PUNCT
ecj-12574	68	1	the	the	DET
ecj-12574	68	2	erg	erg	PROPN
ecj-12574	68	3	was	be	AUX
ecj-12574	68	4	negative	negative	ADJ
ecj-12574	68	5	.	.	PUNCT
ecj-12574	69	1	visual	visual	ADJ
ecj-12574	69	2	evoked	evoke	VERB
ecj-12574	69	3	potentials	potential	NOUN
ecj-12574	69	4	and	and	CCONJ
ecj-12574	69	5	electroretinogram	electroretinogram	PROPN
ecj-12574	69	6	displayed	display	VERB
ecj-12574	69	7	a	a	DET
ecj-12574	69	8	bilateral	bilateral	ADJ
ecj-12574	69	9	adequate	adequate	ADJ
ecj-12574	69	10	latency	latency	NOUN
ecj-12574	69	11	,	,	PUNCT
ecj-12574	69	12	while	while	SCONJ
ecj-12574	69	13	a	a	DET
ecj-12574	69	14	reduced	reduce	VERB
ecj-12574	69	15	amplitude	amplitude	NOUN
ecj-12574	69	16	was	be	AUX
ecj-12574	69	17	observed	observe	VERB
ecj-12574	69	18	in	in	ADP
ecj-12574	69	19	the	the	DET
ecj-12574	69	20	left	left	ADJ
ecj-12574	69	21	eye	eye	NOUN
ecj-12574	69	22	.	.	PUNCT
ecj-12574	70	1	we	we	PRON
ecj-12574	70	2	opted	opt	VERB
ecj-12574	70	3	for	for	ADP
ecj-12574	70	4	a	a	DET
ecj-12574	70	5	slow	slow	ADJ
ecj-12574	70	6	reduction	reduction	NOUN
ecj-12574	70	7	of	of	ADP
ecj-12574	70	8	the	the	DET
ecj-12574	70	9	therapy	therapy	NOUN
ecj-12574	70	10	because	because	SCONJ
ecj-12574	70	11	,	,	PUNCT
ecj-12574	70	12	after	after	ADP
ecj-12574	70	13	a	a	DET
ecj-12574	70	14	rapid	rapid	ADJ
ecj-12574	70	15	reduction	reduction	NOUN
ecj-12574	70	16	attempt	attempt	NOUN
ecj-12574	70	17	,	,	PUNCT
ecj-12574	70	18	she	she	PRON
ecj-12574	70	19	presented	present	VERB
ecj-12574	70	20	a	a	DET
ecj-12574	70	21	new	new	ADJ
ecj-12574	70	22	seizure	seizure	NOUN
ecj-12574	70	23	(	(	PUNCT
ecj-12574	70	24	figure	figure	NOUN
ecj-12574	70	25	2f	2f	NUM
ecj-12574	70	26	)	)	PUNCT
ecj-12574	70	27	.	.	PUNCT
ecj-12574	71	1	repeated	repeat	VERB
ecj-12574	71	2	eegs	eeg	NOUN
ecj-12574	71	3	displayed	display	VERB
ecj-12574	71	4	a	a	DET
ecj-12574	71	5	progressive	progressive	ADJ
ecj-12574	71	6	improvement	improvement	NOUN
ecj-12574	71	7	(	(	PUNCT
ecj-12574	71	8	figur	figur	PROPN
ecj-12574	71	9	2gh	2gh	PROPN
ecj-12574	71	10	)	)	PUNCT
ecj-12574	71	11	.	.	PUNCT
ecj-12574	72	1	visual	visual	ADJ
ecj-12574	72	2	impairment	impairment	NOUN
ecj-12574	72	3	and	and	CCONJ
ecj-12574	72	4	oculo	oculo	ADJ
ecj-12574	72	5	-	-	PUNCT
ecj-12574	72	6	manual	manual	NOUN
ecj-12574	72	7	coordination	coordination	NOUN
ecj-12574	72	8	had	have	VERB
ecj-12574	72	9	a	a	DET
ecj-12574	72	10	slower	slow	ADJ
ecj-12574	72	11	but	but	CCONJ
ecj-12574	72	12	still	still	ADV
ecj-12574	72	13	partial	partial	ADJ
ecj-12574	72	14	resolution	resolution	NOUN
ecj-12574	72	15	.	.	PUNCT
ecj-12574	73	1	a	a	DET
ecj-12574	73	2	second	second	ADJ
ecj-12574	73	3	brain	brain	NOUN
ecj-12574	73	4	mri	mri	NOUN
ecj-12574	73	5	was	be	AUX
ecj-12574	73	6	executed	execute	VERB
ecj-12574	73	7	after	after	ADP
ecj-12574	73	8	18	18	NUM
ecj-12574	73	9	days	day	NOUN
ecj-12574	73	10	hospitalization	hospitalization	NOUN
ecj-12574	73	11	(	(	PUNCT
ecj-12574	73	12	figure	figure	NOUN
ecj-12574	73	13	3b	3b	NUM
ecj-12574	73	14	)	)	PUNCT
ecj-12574	73	15	revealing	reveal	VERB
ecj-12574	73	16	bilateral	bilateral	ADJ
ecj-12574	73	17	caudate	caudate	NOUN
ecj-12574	73	18	and	and	CCONJ
ecj-12574	73	19	putamen	putaman	NOUN
ecj-12574	73	20	hyperintensity	hyperintensity	NOUN
ecj-12574	73	21	,	,	PUNCT
ecj-12574	73	22	associated	associate	VERB
ecj-12574	73	23	to	to	ADP
ecj-12574	73	24	an	an	DET
ecj-12574	73	25	occipital	occipital	NOUN
ecj-12574	73	26	cortical	cortical	ADJ
ecj-12574	73	27	and	and	CCONJ
ecj-12574	73	28	subcortical	subcortical	ADJ
ecj-12574	73	29	hyperintensity	hyperintensity	NOUN
ecj-12574	73	30	,	,	PUNCT
ecj-12574	73	31	with	with	ADP
ecj-12574	73	32	pres	pres	PROPN
ecj-12574	73	33	features	feature	NOUN
ecj-12574	73	34	.	.	PUNCT
ecj-12574	74	1	the	the	DET
ecj-12574	74	2	baby	baby	NOUN
ecj-12574	74	3	was	be	AUX
ecj-12574	74	4	hence	hence	ADV
ecj-12574	74	5	transferred	transfer	VERB
ecj-12574	74	6	to	to	ADP
ecj-12574	74	7	a	a	DET
ecj-12574	74	8	pediatric	pediatric	ADJ
ecj-12574	74	9	rehabilitation	rehabilitation	NOUN
ecj-12574	74	10	center	center	NOUN
ecj-12574	74	11	,	,	PUNCT
ecj-12574	74	12	where	where	SCONJ
ecj-12574	74	13	she	she	PRON
ecj-12574	74	14	showed	show	VERB
ecj-12574	74	15	a	a	DET
ecj-12574	74	16	progressive	progressive	ADJ
ecj-12574	74	17	clinical	clinical	ADJ
ecj-12574	74	18	resolution	resolution	NOUN
ecj-12574	74	19	with	with	ADP
ecj-12574	74	20	oculo	oculo	NOUN
ecj-12574	74	21	-	-	PUNCT
ecj-12574	74	22	manual	manual	NOUN
ecj-12574	74	23	coordination	coordination	NOUN
ecj-12574	74	24	skills	skill	NOUN
ecj-12574	74	25	recovery	recovery	NOUN
ecj-12574	74	26	.	.	PUNCT
ecj-12574	75	1	despite	despite	SCONJ
ecj-12574	75	2	this	this	PRON
ecj-12574	75	3	,	,	PUNCT
ecj-12574	75	4	pev	pev	PROPN
ecj-12574	75	5	flash	flash	PROPN
ecj-12574	75	6	highlights	highlight	NOUN
ecj-12574	75	7	bilateral	bilateral	ADJ
ecj-12574	75	8	severe	severe	ADJ
ecj-12574	75	9	abnormalities	abnormality	NOUN
ecj-12574	75	10	of	of	ADP
ecj-12574	75	11	visual	visual	ADJ
ecj-12574	75	12	conduction	conduction	NOUN
ecj-12574	75	13	.	.	PUNCT
ecj-12574	76	1	an	an	DET
ecj-12574	76	2	mri	mri	NOUN
ecj-12574	76	3	control	control	NOUN
ecj-12574	76	4	after	after	ADP
ecj-12574	76	5	2	2	NUM
ecj-12574	76	6	months	month	NOUN
ecj-12574	76	7	displayed	display	VERB
ecj-12574	76	8	a	a	DET
ecj-12574	76	9	global	global	ADJ
ecj-12574	76	10	hyperintensities	hyperintensitie	NOUN
ecj-12574	76	11	reduction	reduction	NOUN
ecj-12574	76	12	of	of	ADP
ecj-12574	76	13	both	both	DET
ecj-12574	76	14	basal	basal	ADJ
ecj-12574	76	15	ganglia	ganglion	NOUN
ecj-12574	76	16	,	,	PUNCT
ecj-12574	76	17	and	and	CCONJ
ecj-12574	76	18	bilateral	bilateral	ADJ
ecj-12574	76	19	subcortical	subcortical	ADJ
ecj-12574	76	20	parieto	parieto	NOUN
ecj-12574	76	21	-	-	PUNCT
ecj-12574	76	22	occipital	occipital	NOUN
ecj-12574	76	23	white	white	ADJ
ecj-12574	76	24	matter	matter	NOUN
ecj-12574	76	25	.	.	PUNCT
ecj-12574	77	1	a	a	DET
ecj-12574	77	2	moderate	moderate	ADJ
ecj-12574	77	3	cortical	cortical	ADJ
ecj-12574	77	4	-	-	PUNCT
ecj-12574	77	5	subcortical	subcortical	ADJ
ecj-12574	77	6	thinning	thinning	NOUN
ecj-12574	77	7	of	of	ADP
ecj-12574	77	8	the	the	DET
ecj-12574	77	9	bilateral	bilateral	ADJ
ecj-12574	77	10	parieto	parieto	ADJ
ecj-12574	77	11	-	-	PUNCT
ecj-12574	77	12	occipital	occipital	NOUN
ecj-12574	77	13	regions	region	NOUN
ecj-12574	77	14	was	be	AUX
ecj-12574	77	15	revealed	reveal	VERB
ecj-12574	77	16	with	with	ADP
ecj-12574	77	17	consequent	consequent	ADJ
ecj-12574	77	18	ex	ex	ADJ
ecj-12574	77	19	-	-	ADJ
ecj-12574	77	20	vacuo	vacuo	ADJ
ecj-12574	77	21	ventricular	ventricular	ADJ
ecj-12574	77	22	enlargement	enlargement	NOUN
ecj-12574	77	23	(	(	PUNCT
ecj-12574	77	24	figure	figure	NOUN
ecj-12574	77	25	3c	3c	NUM
ecj-12574	77	26	)	)	PUNCT
ecj-12574	77	27	.	.	PUNCT
ecj-12574	78	1	discussion	discussion	NOUN
ecj-12574	78	2	we	we	PRON
ecj-12574	78	3	reported	report	VERB
ecj-12574	78	4	the	the	DET
ecj-12574	78	5	first	first	ADJ
ecj-12574	78	6	pediatric	pediatric	ADJ
ecj-12574	78	7	case	case	NOUN
ecj-12574	78	8	of	of	ADP
ecj-12574	78	9	pres	pre	NOUN
ecj-12574	78	10	due	due	ADP
ecj-12574	78	11	to	to	ADP
ecj-12574	78	12	severe	severe	ADJ
ecj-12574	78	13	citalopram	citalopram	PROPN
ecj-12574	78	14	intoxication	intoxication	NOUN
ecj-12574	78	15	,	,	PUNCT
ecj-12574	78	16	treated	treat	VERB
ecj-12574	78	17	with	with	ADP
ecj-12574	78	18	cyproheptadine	cyproheptadine	NOUN
ecj-12574	78	19	.	.	PUNCT
ecj-12574	79	1	we	we	PRON
ecj-12574	79	2	reviewed	review	VERB
ecj-12574	79	3	the	the	DET
ecj-12574	79	4	previous	previous	ADJ
ecj-12574	79	5	pediatric	pediatric	ADJ
ecj-12574	79	6	literature	literature	NOUN
ecj-12574	79	7	and	and	CCONJ
ecj-12574	79	8	only	only	ADV
ecj-12574	79	9	4	4	NUM
ecj-12574	79	10	papers	paper	NOUN
ecj-12574	79	11	about	about	ADP
ecj-12574	79	12	3	3	NUM
ecj-12574	79	13	infants	infant	NOUN
ecj-12574	79	14	and	and	CCONJ
ecj-12574	79	15	an	an	DET
ecj-12574	79	16	adolescent	adolescent	ADJ
ecj-12574	79	17	were	be	AUX
ecj-12574	79	18	clinically	clinically	ADV
ecj-12574	79	19	described	describe	VERB
ecj-12574	79	20	(	(	PUNCT
ecj-12574	79	21	table	table	NOUN
ecj-12574	79	22	1):13	1):13	PROPN
ecj-12574	79	23	-	-	SYM
ecj-12574	79	24	16	16	NUM
ecj-12574	79	25	two	two	NUM
ecj-12574	79	26	infants	infant	NOUN
ecj-12574	79	27	presenting	present	VERB
ecj-12574	79	28	seizures	seizure	NOUN
ecj-12574	79	29	,	,	PUNCT
ecj-12574	79	30	requiring	require	VERB
ecj-12574	79	31	anti	anti	ADJ
ecj-12574	79	32	-	-	ADJ
ecj-12574	79	33	seizures	seizures	ADJ
ecj-12574	79	34	therapy	therapy	NOUN
ecj-12574	79	35	and	and	CCONJ
ecj-12574	79	36	with	with	ADP
ecj-12574	79	37	ocular	ocular	ADJ
ecj-12574	79	38	involvement	involvement	NOUN
ecj-12574	79	39	:	:	PUNCT
ecj-12574	79	40	nystagmus	nystagmus	ADJ
ecj-12574	79	41	,	,	PUNCT
ecj-12574	79	42	mydriasis	mydriasis	NOUN
ecj-12574	79	43	and	and	CCONJ
ecj-12574	79	44	absence	absence	NOUN
ecj-12574	79	45	of	of	ADP
ecj-12574	79	46	visual	visual	ADJ
ecj-12574	79	47	tracking	tracking	NOUN
ecj-12574	79	48	.	.	PUNCT
ecj-12574	80	1	no	no	DET
ecj-12574	80	2	precise	precise	ADJ
ecj-12574	80	3	information	information	NOUN
ecj-12574	80	4	about	about	ADP
ecj-12574	80	5	posology	posology	NOUN
ecj-12574	80	6	assumed	assume	VERB
ecj-12574	80	7	was	be	AUX
ecj-12574	80	8	available	available	ADJ
ecj-12574	80	9	and	and	CCONJ
ecj-12574	80	10	none	none	NOUN
ecj-12574	80	11	of	of	ADP
ecj-12574	80	12	them	they	PRON
ecj-12574	80	13	displayed	display	VERB
ecj-12574	80	14	brain	brain	NOUN
ecj-12574	80	15	imaging	imaging	NOUN
ecj-12574	80	16	involvement	involvement	NOUN
ecj-12574	80	17	and/or	and/or	CCONJ
ecj-12574	80	18	had	have	VERB
ecj-12574	80	19	permanent	permanent	ADJ
ecj-12574	80	20	sequelae	sequelae	NOUN
ecj-12574	80	21	.	.	PUNCT
ecj-12574	81	1	analyzing	analyze	VERB
ecj-12574	81	2	literature	literature	NOUN
ecj-12574	81	3	,	,	PUNCT
ecj-12574	81	4	these	these	DET
ecj-12574	81	5	pediatric	pediatric	ADJ
ecj-12574	81	6	patients	patient	NOUN
ecj-12574	81	7	presented	present	VERB
ecj-12574	81	8	acute	acute	ADJ
ecj-12574	81	9	reversible	reversible	ADJ
ecj-12574	81	10	symptoms	symptom	NOUN
ecj-12574	81	11	,	,	PUNCT
ecj-12574	81	12	not	not	PART
ecj-12574	81	13	requiring	require	VERB
ecj-12574	81	14	cyproheptadine	cyproheptadine	NOUN
ecj-12574	81	15	.	.	PUNCT
ecj-12574	82	1	on	on	ADP
ecj-12574	82	2	the	the	DET
ecj-12574	82	3	contrary	contrary	NOUN
ecj-12574	82	4	,	,	PUNCT
ecj-12574	82	5	in	in	ADP
ecj-12574	82	6	our	our	PRON
ecj-12574	82	7	patient	patient	NOUN
ecj-12574	82	8	,	,	PUNCT
ecj-12574	82	9	seizures	seizure	NOUN
ecj-12574	82	10	occurred	occur	VERB
ecj-12574	82	11	suddenly	suddenly	ADV
ecj-12574	82	12	in	in	ADP
ecj-12574	82	13	our	our	PRON
ecj-12574	82	14	patient	patient	NOUN
ecj-12574	82	15	,	,	PUNCT
ecj-12574	82	16	and	and	CCONJ
ecj-12574	82	17	within	within	ADP
ecj-12574	82	18	a	a	DET
ecj-12574	82	19	few	few	ADJ
ecj-12574	82	20	days	day	NOUN
ecj-12574	82	21	,	,	PUNCT
ecj-12574	82	22	she	she	PRON
ecj-12574	82	23	showed	show	VERB
ecj-12574	82	24	a	a	DET
ecj-12574	82	25	progressive	progressive	ADJ
ecj-12574	82	26	neurological	neurological	ADJ
ecj-12574	82	27	impairment	impairment	NOUN
ecj-12574	82	28	and	and	CCONJ
ecj-12574	82	29	a	a	DET
ecj-12574	82	30	neuroradiological	neuroradiological	ADJ
ecj-12574	82	31	worsening	worsening	NOUN
ecj-12574	82	32	,	,	PUNCT
ecj-12574	82	33	requiring	require	VERB
ecj-12574	82	34	antidote	antidote	NOUN
ecj-12574	82	35	treatment	treatment	NOUN
ecj-12574	82	36	with	with	ADP
ecj-12574	82	37	cyproheptadine.4	cyproheptadine.4	PROPN
ecj-12574	82	38	her	her	PRON
ecj-12574	82	39	brain	brain	NOUN
ecj-12574	82	40	mri	mri	NOUN
ecj-12574	82	41	displayed	display	VERB
ecj-12574	82	42	both	both	CCONJ
ecj-12574	82	43	a	a	DET
ecj-12574	82	44	vasogenic	vasogenic	ADJ
ecj-12574	82	45	and	and	CCONJ
ecj-12574	82	46	cytotoxic	cytotoxic	ADJ
ecj-12574	82	47	edema	edema	NOUN
ecj-12574	82	48	damage	damage	NOUN
ecj-12574	82	49	at	at	ADP
ecj-12574	82	50	the	the	DET
ecj-12574	82	51	posterior	posterior	ADJ
ecj-12574	82	52	cortical	cortical	ADJ
ecj-12574	82	53	regions	region	NOUN
ecj-12574	82	54	with	with	ADP
ecj-12574	82	55	consequent	consequent	ADJ
ecj-12574	82	56	parieto	parieto	NOUN
ecj-12574	82	57	-	-	PUNCT
ecj-12574	82	58	occipital	occipital	NOUN
ecj-12574	82	59	neuronal	neuronal	ADJ
ecj-12574	82	60	loss	loss	NOUN
ecj-12574	82	61	and	and	CCONJ
ecj-12574	82	62	the	the	DET
ecj-12574	82	63	transient	transient	ADJ
ecj-12574	82	64	involvement	involvement	NOUN
ecj-12574	82	65	at	at	ADP
ecj-12574	82	66	the	the	DET
ecj-12574	82	67	level	level	NOUN
ecj-12574	82	68	of	of	ADP
ecj-12574	82	69	the	the	DET
ecj-12574	82	70	basal	basal	ADJ
ecj-12574	82	71	ganglia	ganglia	NOUN
ecj-12574	82	72	,	,	PUNCT
ecj-12574	82	73	compatible	compatible	ADJ
ecj-12574	82	74	with	with	ADP
ecj-12574	82	75	transient	transient	ADJ
ecj-12574	82	76	toxic	toxic	ADJ
ecj-12574	82	77	damage	damage	NOUN
ecj-12574	82	78	due	due	ADP
ecj-12574	82	79	to	to	ADP
ecj-12574	82	80	overstimulation	overstimulation	NOUN
ecj-12574	82	81	of	of	ADP
ecj-12574	82	82	serotoninergic	serotoninergic	ADJ
ecj-12574	82	83	receptors.6	receptors.6	NOUN
ecj-12574	82	84	-	-	SYM
ecj-12574	82	85	8	8	NUM
ecj-12574	82	86	this	this	DET
ecj-12574	82	87	edemigenous	edemigenous	ADJ
ecj-12574	82	88	involvement	involvement	NOUN
ecj-12574	82	89	typical	typical	ADJ
ecj-12574	82	90	of	of	ADP
ecj-12574	82	91	pres	pres	PROPN
ecj-12574	82	92	had	have	VERB
ecj-12574	82	93	a	a	DET
ecj-12574	82	94	sure	sure	ADJ
ecj-12574	82	95	causative	causative	ADJ
ecj-12574	82	96	role	role	NOUN
ecj-12574	82	97	both	both	PRON
ecj-12574	82	98	in	in	ADP
ecj-12574	82	99	seizures	seizure	NOUN
ecj-12574	82	100	,	,	PUNCT
ecj-12574	82	101	visual	visual	ADJ
ecj-12574	82	102	impairment	impairment	NOUN
ecj-12574	82	103	occurrence	occurrence	NOUN
ecj-12574	82	104	and	and	CCONJ
ecj-12574	82	105	progressive	progressive	ADJ
ecj-12574	82	106	neurological	neurological	ADJ
ecj-12574	82	107	decay	decay	NOUN
ecj-12574	82	108	.	.	PUNCT
ecj-12574	83	1	we	we	PRON
ecj-12574	83	2	could	could	AUX
ecj-12574	83	3	only	only	ADV
ecj-12574	83	4	hypothesize	hypothesize	VERB
ecj-12574	83	5	that	that	SCONJ
ecj-12574	83	6	the	the	DET
ecj-12574	83	7	progressive	progressive	ADJ
ecj-12574	83	8	occurrence	occurrence	NOUN
ecj-12574	83	9	of	of	ADP
ecj-12574	83	10	symptoms	symptom	NOUN
ecj-12574	83	11	could	could	AUX
ecj-12574	83	12	be	be	AUX
ecj-12574	83	13	due	due	ADJ
ecj-12574	83	14	to	to	ADP
ecj-12574	83	15	variable	variable	ADJ
ecj-12574	83	16	protein	protein	NOUN
ecj-12574	83	17	binding	bind	VERB
ecj-12574	83	18	,	,	PUNCT
ecj-12574	83	19	floating	float	VERB
ecj-12574	83	20	volume	volume	NOUN
ecj-12574	83	21	of	of	ADP
ecj-12574	83	22	distribution	distribution	NOUN
ecj-12574	83	23	and	and	CCONJ
ecj-12574	83	24	rates	rate	NOUN
ecj-12574	83	25	of	of	ADP
ecj-12574	83	26	hepatic	hepatic	ADJ
ecj-12574	83	27	metabolism	metabolism	NOUN
ecj-12574	83	28	and	and	CCONJ
ecj-12574	83	29	excretion	excretion	NOUN
ecj-12574	83	30	of	of	ADP
ecj-12574	83	31	drugs	drug	NOUN
ecj-12574	83	32	,	,	PUNCT
ecj-12574	83	33	typical	typical	ADJ
ecj-12574	83	34	of	of	ADP
ecj-12574	83	35	infants	infant	NOUN
ecj-12574	83	36	,	,	PUNCT
ecj-12574	83	37	that	that	PRON
ecj-12574	83	38	could	could	AUX
ecj-12574	83	39	alter	alter	VERB
ecj-12574	83	40	citalopram	citalopram	PROPN
ecj-12574	83	41	pharmacodynamics	pharmacodynamic	NOUN
ecj-12574	83	42	and	and	CCONJ
ecj-12574	83	43	clinical	clinical	ADJ
ecj-12574	83	44	evolution.13	evolution.13	NOUN
ecj-12574	83	45	-	-	PUNCT
ecj-12574	83	46	17	17	NUM
ecj-12574	83	47	in	in	ADP
ecj-12574	83	48	literature	literature	NOUN
ecj-12574	83	49	,	,	PUNCT
ecj-12574	83	50	no	no	DET
ecj-12574	83	51	evidence	evidence	NOUN
ecj-12574	83	52	of	of	ADP
ecj-12574	83	53	cyproheptadine	cyproheptadine	NOUN
ecj-12574	83	54	use	use	NOUN
ecj-12574	83	55	as	as	ADP
ecj-12574	83	56	antidote	antidote	NOUN
ecj-12574	83	57	in	in	ADP
ecj-12574	83	58	case	case	NOUN
ecj-12574	83	59	of	of	ADP
ecj-12574	83	60	pediatric	pediatric	ADJ
ecj-12574	83	61	intoxications	intoxication	NOUN
ecj-12574	83	62	and	and	CCONJ
ecj-12574	83	63	few	few	ADJ
ecj-12574	83	64	evidences	evidence	NOUN
ecj-12574	83	65	are	be	AUX
ecj-12574	83	66	available	available	ADJ
ecj-12574	83	67	case	case	NOUN
ecj-12574	83	68	report	report	NOUN
ecj-12574	83	69	figure	figure	NOUN
ecj-12574	83	70	2	2	NUM
ecj-12574	83	71	.	.	X
ecj-12574	83	72	eeg	eeg	NOUN
ecj-12574	83	73	evolution	evolution	NOUN
ecj-12574	83	74	after	after	ADP
ecj-12574	83	75	acute	acute	PROPN
ecj-12574	83	76	citalopram	citalopram	PROPN
ecj-12574	83	77	intoxication	intoxication	NOUN
ecj-12574	83	78	.	.	PUNCT
ecj-12574	84	1	a	a	DET
ecj-12574	84	2	)	)	PUNCT
ecj-12574	84	3	sleep	sleep	NOUN
ecj-12574	84	4	eeg	eeg	NOUN
ecj-12574	84	5	:	:	PUNCT
ecj-12574	84	6	regular	regular	ADJ
ecj-12574	84	7	eeg	eeg	NOUN
ecj-12574	84	8	without	without	ADP
ecj-12574	84	9	paroxysmal	paroxysmal	ADJ
ecj-12574	84	10	discharges	discharge	NOUN
ecj-12574	84	11	observed	observe	VERB
ecj-12574	84	12	.	.	PUNCT
ecj-12574	85	1	artifacts	artifact	NOUN
ecj-12574	85	2	on	on	ADP
ecj-12574	85	3	right	right	ADJ
ecj-12574	85	4	temporal	temporal	ADJ
ecj-12574	85	5	regions	region	NOUN
ecj-12574	85	6	(	(	PUNCT
ecj-12574	85	7	admission	admission	NOUN
ecj-12574	85	8	)	)	PUNCT
ecj-12574	85	9	;	;	PUNCT
ecj-12574	85	10	b	b	X
ecj-12574	85	11	)	)	PUNCT
ecj-12574	85	12	left	leave	VERB
ecj-12574	85	13	rhythmical	rhythmical	ADJ
ecj-12574	85	14	theta	theta	NOUN
ecj-12574	85	15	activity	activity	NOUN
ecj-12574	85	16	on	on	ADP
ecj-12574	85	17	the	the	DET
ecj-12574	85	18	left	left	NOUN
ecj-12574	85	19	to	to	ADP
ecj-12574	85	20	regions	region	NOUN
ecj-12574	85	21	during	during	ADP
ecj-12574	85	22	sleep	sleep	NOUN
ecj-12574	85	23	(	(	PUNCT
ecj-12574	85	24	2nd	2nd	ADJ
ecj-12574	85	25	day	day	NOUN
ecj-12574	85	26	hospitalization	hospitalization	NOUN
ecj-12574	85	27	)	)	PUNCT
ecj-12574	85	28	;	;	PUNCT
ecj-12574	85	29	c	c	X
ecj-12574	85	30	)	)	PUNCT
ecj-12574	85	31	left	leave	VERB
ecj-12574	85	32	temporo	temporo	PROPN
ecj-12574	85	33	-	-	PUNCT
ecj-12574	85	34	occipital	occipital	NOUN
ecj-12574	85	35	seizure	seizure	NOUN
ecj-12574	85	36	(	(	PUNCT
ecj-12574	85	37	4th	4th	ADJ
ecj-12574	85	38	day	day	NOUN
ecj-12574	85	39	hospitalization	hospitalization	NOUN
ecj-12574	85	40	)	)	PUNCT
ecj-12574	85	41	;	;	PUNCT
ecj-12574	85	42	d	d	X
ecj-12574	85	43	)	)	PUNCT
ecj-12574	85	44	secondary	secondary	ADJ
ecj-12574	85	45	bilateralization	bilateralization	NOUN
ecj-12574	85	46	of	of	ADP
ecj-12574	85	47	the	the	DET
ecj-12574	85	48	left	left	NOUN
ecj-12574	85	49	to	to	PART
ecj-12574	85	50	seizure	seizure	VERB
ecj-12574	85	51	(	(	PUNCT
ecj-12574	85	52	4th	4th	ADJ
ecj-12574	85	53	day	day	NOUN
ecj-12574	85	54	hospitalization	hospitalization	NOUN
ecj-12574	85	55	)	)	PUNCT
ecj-12574	85	56	;	;	PUNCT
ecj-12574	86	1	e	e	X
ecj-12574	86	2	)	)	PUNCT
ecj-12574	86	3	sleep	sleep	NOUN
ecj-12574	86	4	eeg	eeg	NOUN
ecj-12574	86	5	after	after	ADP
ecj-12574	86	6	2	2	NUM
ecj-12574	86	7	hours	hour	NOUN
ecj-12574	86	8	of	of	ADP
ecj-12574	86	9	cyproheptadine	cyproheptadine	NOUN
ecj-12574	86	10	ev	ev	ADP
ecj-12574	86	11	infusion	infusion	NOUN
ecj-12574	86	12	(	(	PUNCT
ecj-12574	86	13	5th	5th	ADJ
ecj-12574	86	14	day	day	NOUN
ecj-12574	86	15	hospitalization	hospitalization	NOUN
ecj-12574	86	16	)	)	PUNCT
ecj-12574	86	17	;	;	PUNCT
ecj-12574	87	1	f	f	X
ecj-12574	87	2	)	)	PUNCT
ecj-12574	87	3	right	right	ADJ
ecj-12574	87	4	temporo	temporo	PROPN
ecj-12574	87	5	-	-	PUNCT
ecj-12574	87	6	occipital	occipital	NOUN
ecj-12574	87	7	seizure	seizure	NOUN
ecj-12574	87	8	after	after	ADP
ecj-12574	87	9	cyproheptadine	cyproheptadine	NOUN
ecj-12574	87	10	iv	iv	NUM
ecj-12574	87	11	infusion	infusion	NOUN
ecj-12574	87	12	dosage	dosage	NOUN
ecj-12574	87	13	reduction	reduction	NOUN
ecj-12574	87	14	(	(	PUNCT
ecj-12574	87	15	6th	6th	ADJ
ecj-12574	87	16	day	day	NOUN
ecj-12574	87	17	hospitalization	hospitalization	NOUN
ecj-12574	87	18	)	)	PUNCT
ecj-12574	87	19	;	;	PUNCT
ecj-12574	87	20	g	g	X
ecj-12574	87	21	)	)	PUNCT
ecj-12574	87	22	sleep	sleep	NOUN
ecj-12574	87	23	eeg	eeg	NOUN
ecj-12574	87	24	without	without	ADP
ecj-12574	87	25	paroxysmal	paroxysmal	ADJ
ecj-12574	87	26	discharges	discharge	NOUN
ecj-12574	87	27	(	(	PUNCT
ecj-12574	87	28	22nd	22nd	ADJ
ecj-12574	87	29	day	day	NOUN
ecj-12574	87	30	hospitalization	hospitalization	NOUN
ecj-12574	87	31	)	)	PUNCT
ecj-12574	87	32	;	;	PUNCT
ecj-12574	87	33	h	h	X
ecj-12574	87	34	)	)	PUNCT
ecj-12574	87	35	awake	awake	ADJ
ecj-12574	87	36	eeg	eeg	NOUN
ecj-12574	87	37	with	with	ADP
ecj-12574	87	38	persistent	persistent	ADJ
ecj-12574	87	39	right	right	ADJ
ecj-12574	87	40	slow	slow	ADJ
ecj-12574	87	41	occipital	occipital	NOUN
ecj-12574	87	42	activity	activity	NOUN
ecj-12574	87	43	without	without	ADP
ecj-12574	87	44	paroxysmal	paroxysmal	ADJ
ecj-12574	87	45	discharges	discharge	NOUN
ecj-12574	87	46	(	(	PUNCT
ecj-12574	87	47	60th	60th	ADJ
ecj-12574	87	48	day	day	NOUN
ecj-12574	87	49	hospitalization	hospitalization	NOUN
ecj-12574	87	50	)	)	PUNCT
ecj-12574	87	51	.	.	PUNCT
ecj-12574	88	1	[	[	X
ecj-12574	88	2	emergency	emergency	NOUN
ecj-12574	88	3	care	care	NOUN
ecj-12574	88	4	journal	journal	PROPN
ecj-12574	88	5	2024	2024	NUM
ecj-12574	88	6	;	;	PUNCT
ecj-12574	88	7	20:12574	20:12574	NUM
ecj-12574	88	8	]	]	X
ecj-12574	89	1	[	[	X
ecj-12574	89	2	page	page	NOUN
ecj-12574	89	3	67	67	NUM
ecj-12574	89	4	]	]	X
ecj-12574	89	5	non	non	ADJ
ecj-12574	89	6	-co	-co	PROPN
ecj-12574	89	7	mmerc	mmerc	PROPN
ecj-12574	89	8	ial	ial	PROPN
ecj-12574	89	9	us	us	PROPN
ecj-12574	89	10	e	e	NOUN
ecj-12574	89	11	o	o	X
ecj-12574	89	12	nly	nly	ADV
ecj-12574	89	13	about	about	ADP
ecj-12574	89	14	anti	anti	ADJ
ecj-12574	89	15	-	-	ADJ
ecj-12574	89	16	seizures	seizures	ADJ
ecj-12574	89	17	therapy	therapy	NOUN
ecj-12574	89	18	in	in	ADP
ecj-12574	89	19	ss	ss	PROPN
ecj-12574	89	20	.	.	PUNCT
ecj-12574	89	21	cyproheptadine	cyproheptadine	NOUN
ecj-12574	89	22	is	be	AUX
ecj-12574	89	23	an	an	DET
ecj-12574	89	24	histamine1	histamine1	NOUN
ecj-12574	89	25	receptor	receptor	NOUN
ecj-12574	89	26	antagonist	antagonist	NOUN
ecj-12574	89	27	,	,	PUNCT
ecj-12574	89	28	available	available	ADJ
ecj-12574	89	29	only	only	ADV
ecj-12574	89	30	in	in	ADP
ecj-12574	89	31	oral	oral	ADJ
ecj-12574	89	32	form	form	NOUN
ecj-12574	89	33	and	and	CCONJ
ecj-12574	89	34	it	it	PRON
ecj-12574	89	35	has	have	AUX
ecj-12574	89	36	increasing	increase	VERB
ecj-12574	89	37	evidences	evidence	NOUN
ecj-12574	89	38	as	as	ADP
ecj-12574	89	39	antidotal	antidotal	ADJ
ecj-12574	89	40	therapy	therapy	NOUN
ecj-12574	89	41	in	in	ADP
ecj-12574	89	42	ss	ss	PROPN
ecj-12574	89	43	.	.	PUNCT
ecj-12574	90	1	as	as	ADP
ecj-12574	90	2	side	side	NOUN
ecj-12574	90	3	effects	effect	NOUN
ecj-12574	90	4	it	it	PRON
ecj-12574	90	5	could	could	AUX
ecj-12574	90	6	cause	cause	VERB
ecj-12574	90	7	hypotension	hypotension	NOUN
ecj-12574	90	8	(	(	PUNCT
ecj-12574	90	9	not	not	PART
ecj-12574	90	10	observed	observe	VERB
ecj-12574	90	11	in	in	ADP
ecj-12574	90	12	our	our	PRON
ecj-12574	90	13	patient	patient	NOUN
ecj-12574	90	14	)	)	PUNCT
ecj-12574	90	15	and	and	CCONJ
ecj-12574	90	16	sedation	sedation	NOUN
ecj-12574	90	17	,	,	PUNCT
ecj-12574	90	18	that	that	PRON
ecj-12574	90	19	could	could	AUX
ecj-12574	90	20	have	have	VERB
ecj-12574	90	21	a	a	DET
ecj-12574	90	22	secondary	secondary	ADJ
ecj-12574	90	23	positive	positive	ADJ
ecj-12574	90	24	effect	effect	NOUN
ecj-12574	90	25	in	in	ADP
ecj-12574	90	26	seizures	seizure	NOUN
ecj-12574	90	27	control	control	NOUN
ecj-12574	90	28	:	:	PUNCT
ecj-12574	90	29	we	we	PRON
ecj-12574	90	30	observe	observe	VERB
ecj-12574	90	31	a	a	DET
ecj-12574	90	32	focal	focal	ADJ
ecj-12574	90	33	seizures	seizure	NOUN
ecj-12574	90	34	resurgence	resurgence	NOUN
ecj-12574	90	35	during	during	ADP
ecj-12574	90	36	a	a	DET
ecj-12574	90	37	rapid	rapid	ADJ
ecj-12574	90	38	cyproheptadine	cyproheptadine	NOUN
ecj-12574	90	39	reduction	reduction	NOUN
ecj-12574	90	40	attempt	attempt	NOUN
ecj-12574	90	41	.	.	PUNCT
ecj-12574	91	1	antiseizures	antiseizure	VERB
ecj-12574	91	2	drugs	drug	NOUN
ecj-12574	91	3	such	such	ADJ
ecj-12574	91	4	as	as	ADP
ecj-12574	91	5	valproic	valproic	ADJ
ecj-12574	91	6	acid	acid	NOUN
ecj-12574	91	7	,	,	PUNCT
ecj-12574	91	8	lamotrigine	lamotrigine	NOUN
ecj-12574	91	9	,	,	PUNCT
ecj-12574	91	10	gabapentin	gabapentin	NOUN
ecj-12574	91	11	,	,	PUNCT
ecj-12574	91	12	pregabalin	pregabalin	NOUN
ecj-12574	91	13	,	,	PUNCT
ecj-12574	91	14	topiramate	topiramate	NOUN
ecj-12574	91	15	and	and	CCONJ
ecj-12574	91	16	carbamazepine	carbamazepine	NOUN
ecj-12574	91	17	,	,	PUNCT
ecj-12574	91	18	phenytoin	phenytoin	NOUN
ecj-12574	91	19	and	and	CCONJ
ecj-12574	91	20	oxcarbazepine	oxcarbazepine	NOUN
ecj-12574	91	21	could	could	AUX
ecj-12574	91	22	have	have	VERB
ecj-12574	91	23	serotoninergic	serotoninergic	ADJ
ecj-12574	91	24	properties	property	NOUN
ecj-12574	91	25	and	and	CCONJ
ecj-12574	91	26	should	should	AUX
ecj-12574	91	27	be	be	AUX
ecj-12574	91	28	avoided	avoid	VERB
ecj-12574	91	29	in	in	ADP
ecj-12574	91	30	case	case	NOUN
ecj-12574	91	31	of	of	ADP
ecj-12574	91	32	ss.18	ss.18	NOUN
ecj-12574	91	33	in	in	ADP
ecj-12574	91	34	conclusion	conclusion	NOUN
ecj-12574	91	35	,	,	PUNCT
ecj-12574	91	36	pediatric	pediatric	ADJ
ecj-12574	91	37	citalopram	citalopram	PROPN
ecj-12574	91	38	intoxication	intoxication	NOUN
ecj-12574	91	39	could	could	AUX
ecj-12574	91	40	represent	represent	VERB
ecj-12574	91	41	a	a	DET
ecj-12574	91	42	severe	severe	ADJ
ecj-12574	91	43	neurological	neurological	ADJ
ecj-12574	91	44	pediatric	pediatric	ADJ
ecj-12574	91	45	emergency	emergency	NOUN
ecj-12574	91	46	with	with	ADP
ecj-12574	91	47	pres	pres	PROPN
ecj-12574	91	48	features	feature	NOUN
ecj-12574	91	49	.	.	PUNCT
ecj-12574	92	1	cyproheptadine	cyproheptadine	NOUN
ecj-12574	92	2	could	could	AUX
ecj-12574	92	3	be	be	AUX
ecj-12574	92	4	a	a	DET
ecj-12574	92	5	safe	safe	ADJ
ecj-12574	92	6	and	and	CCONJ
ecj-12574	92	7	effective	effective	ADJ
ecj-12574	92	8	antidote	antidote	NOUN
ecj-12574	92	9	to	to	PART
ecj-12574	92	10	minimize	minimize	VERB
ecj-12574	92	11	the	the	DET
ecj-12574	92	12	side	side	NOUN
ecj-12574	92	13	effects	effect	NOUN
ecj-12574	92	14	of	of	ADP
ecj-12574	92	15	citalopram	citalopram	PROPN
ecj-12574	92	16	intoxication	intoxication	NOUN
ecj-12574	92	17	.	.	PUNCT
ecj-12574	93	1	further	further	ADJ
ecj-12574	93	2	studies	study	NOUN
ecj-12574	93	3	are	be	AUX
ecj-12574	93	4	required	require	VERB
ecj-12574	93	5	to	to	PART
ecj-12574	93	6	understand	understand	VERB
ecj-12574	93	7	the	the	DET
ecj-12574	93	8	pharmacokinetics	pharmacokinetic	NOUN
ecj-12574	93	9	of	of	ADP
ecj-12574	93	10	this	this	DET
ecj-12574	93	11	drug	drug	NOUN
ecj-12574	93	12	and	and	CCONJ
ecj-12574	93	13	the	the	DET
ecj-12574	93	14	pathophysiology	pathophysiology	NOUN
ecj-12574	93	15	of	of	ADP
ecj-12574	93	16	this	this	DET
ecj-12574	93	17	cortical	cortical	ADJ
ecj-12574	93	18	and	and	CCONJ
ecj-12574	93	19	subcortical	subcortical	ADJ
ecj-12574	93	20	involvement	involvement	NOUN
ecj-12574	93	21	.	.	PUNCT
ecj-12574	94	1	case	case	NOUN
ecj-12574	94	2	report	report	NOUN
ecj-12574	94	3	figure	figure	NOUN
ecj-12574	94	4	3	3	NUM
ecj-12574	94	5	.	.	PUNCT
ecj-12574	94	6	brain	brain	NOUN
ecj-12574	94	7	mri	mri	NOUN
ecj-12574	94	8	evolution	evolution	NOUN
ecj-12574	94	9	after	after	ADP
ecj-12574	94	10	citalopram	citalopram	PROPN
ecj-12574	94	11	intoxication	intoxication	NOUN
ecj-12574	94	12	.	.	PUNCT
ecj-12574	95	1	a	a	DET
ecj-12574	95	2	)	)	PUNCT
ecj-12574	95	3	normal	normal	ADJ
ecj-12574	95	4	second	second	ADJ
ecj-12574	95	5	day	day	NOUN
ecj-12574	95	6	brain	brain	NOUN
ecj-12574	95	7	mri	mri	NOUN
ecj-12574	95	8	;	;	PUNCT
ecj-12574	95	9	b	b	X
ecj-12574	95	10	)	)	PUNCT
ecj-12574	95	11	bilateral	bilateral	ADJ
ecj-12574	95	12	caudate	caudate	NOUN
ecj-12574	95	13	and	and	CCONJ
ecj-12574	95	14	putamen	putaman	NOUN
ecj-12574	95	15	hyperintensity	hyperintensity	NOUN
ecj-12574	95	16	,	,	PUNCT
ecj-12574	95	17	associated	associate	VERB
ecj-12574	95	18	to	to	ADP
ecj-12574	95	19	an	an	DET
ecj-12574	95	20	occipital	occipital	NOUN
ecj-12574	95	21	cortical	cortical	ADJ
ecj-12574	95	22	and	and	CCONJ
ecj-12574	95	23	subcortical	subcortical	ADJ
ecj-12574	95	24	hyperintensity	hyperintensity	NOUN
ecj-12574	95	25	,	,	PUNCT
ecj-12574	95	26	similar	similar	ADJ
ecj-12574	95	27	to	to	ADP
ecj-12574	95	28	pres	pre	NOUN
ecj-12574	95	29	at	at	ADP
ecj-12574	95	30	18th	18th	ADJ
ecj-12574	95	31	day	day	NOUN
ecj-12574	95	32	hospitalization	hospitalization	NOUN
ecj-12574	95	33	;	;	PUNCT
ecj-12574	95	34	c	c	X
ecj-12574	95	35	)	)	PUNCT
ecj-12574	95	36	basal	basal	ADJ
ecj-12574	95	37	ganglia	ganglia	NOUN
ecj-12574	95	38	,	,	PUNCT
ecj-12574	95	39	and	and	CCONJ
ecj-12574	95	40	bilateral	bilateral	ADJ
ecj-12574	95	41	subcortical	subcortical	ADJ
ecj-12574	95	42	parieto	parieto	NOUN
ecj-12574	95	43	-	-	PUNCT
ecj-12574	95	44	occipital	occipital	NOUN
ecj-12574	95	45	white	white	ADJ
ecj-12574	95	46	matter	matter	NOUN
ecj-12574	95	47	hyperintensities	hyperintensitie	NOUN
ecj-12574	95	48	reduction	reduction	NOUN
ecj-12574	95	49	without	without	ADP
ecj-12574	95	50	volumetric	volumetric	NOUN
ecj-12574	95	51	modifications	modification	NOUN
ecj-12574	95	52	.	.	PUNCT
ecj-12574	96	1	moderate	moderate	ADJ
ecj-12574	96	2	corticalsubcortical	corticalsubcortical	ADJ
ecj-12574	96	3	bilateral	bilateral	ADJ
ecj-12574	96	4	thinning	thinning	NOUN
ecj-12574	96	5	of	of	ADP
ecj-12574	96	6	the	the	DET
ecj-12574	96	7	parieto	parieto	ADJ
ecj-12574	96	8	-	-	PUNCT
ecj-12574	96	9	occipital	occipital	NOUN
ecj-12574	96	10	regions	region	NOUN
ecj-12574	96	11	with	with	ADP
ecj-12574	96	12	ex	ex	ADJ
ecj-12574	96	13	-	-	ADJ
ecj-12574	96	14	vacuo	vacuo	ADJ
ecj-12574	96	15	ventricular	ventricular	ADJ
ecj-12574	96	16	enlargement	enlargement	NOUN
ecj-12574	96	17	.	.	PUNCT
ecj-12574	97	1	[	[	X
ecj-12574	97	2	page	page	NOUN
ecj-12574	97	3	68	68	NUM
ecj-12574	97	4	]	]	PUNCT
ecj-12574	98	1	[	[	X
ecj-12574	98	2	emergency	emergency	NOUN
ecj-12574	98	3	care	care	NOUN
ecj-12574	98	4	journal	journal	PROPN
ecj-12574	98	5	2024	2024	NUM
ecj-12574	98	6	;	;	PUNCT
ecj-12574	98	7	20:12574	20:12574	NUM
ecj-12574	98	8	]	]	PUNCT
ecj-12574	98	9	table	table	NOUN
ecj-12574	98	10	1	1	NUM
ecj-12574	98	11	.	.	PUNCT
ecj-12574	98	12	literature	literature	NOUN
ecj-12574	98	13	review	review	PROPN
ecj-12574	98	14	of	of	ADP
ecj-12574	98	15	pediatric	pediatric	ADJ
ecj-12574	98	16	patients	patient	NOUN
ecj-12574	98	17	with	with	ADP
ecj-12574	98	18	citalopram	citalopram	PROPN
ecj-12574	98	19	intoxication	intoxication	NOUN
ecj-12574	98	20	.	.	PUNCT
ecj-12574	99	1	paper	paper	NOUN
ecj-12574	99	2	pt	pt	PROPN
ecj-12574	99	3	n	n	CCONJ
ecj-12574	99	4	age	age	NOUN
ecj-12574	99	5	sex	sex	NOUN
ecj-12574	99	6	dosage	dosage	NOUN
ecj-12574	99	7	plasma	plasma	NOUN
ecj-12574	99	8	dosage	dosage	NOUN
ecj-12574	99	9	symptoms	symptom	NOUN
ecj-12574	99	10	imaging	image	VERB
ecj-12574	99	11	therapy	therapy	NOUN
ecj-12574	99	12	outcome	outcome	VERB
ecj-12574	99	13	neurological	neurological	ADJ
ecj-12574	99	14	cardiological	cardiological	PROPN
ecj-12574	99	15	masullo	masullo	PROPN
ecj-12574	99	16	,	,	PUNCT
ecj-12574	99	17	2006¹³	2006¹³	NUM
ecj-12574	99	18	1	1	NUM
ecj-12574	99	19	10	10	NUM
ecj-12574	99	20	m	m	NOUN
ecj-12574	99	21	f	f	NOUN
ecj-12574	99	22	na	na	ADP
ecj-12574	99	23	1400	1400	NUM
ecj-12574	99	24	ng/	ng/	ADJ
ecj-12574	99	25	horizontal	horizontal	ADJ
ecj-12574	99	26	nystagmus	nystagmus	NOUN
ecj-12574	99	27	,	,	PUNCT
ecj-12574	99	28	na	na	NOUN
ecj-12574	99	29	mdz	mdz	PROPN
ecj-12574	99	30	+	+	PROPN
ecj-12574	99	31	pht	pht	PROPN
ecj-12574	99	32	+	+	CCONJ
ecj-12574	99	33	ns	ns	NUM
ecj-12574	99	34	ml	ml	NOUN
ecj-12574	99	35	(	(	PUNCT
ecj-12574	99	36	1	1	NUM
ecj-12574	99	37	h	h	NOUN
ecj-12574	99	38	)	)	PUNCT
ecj-12574	99	39	,	,	PUNCT
ecj-12574	99	40	3	3	NUM
ecj-12574	99	41	tc	tc	NOUN
ecj-12574	99	42	seizures	seizure	NOUN
ecj-12574	99	43	pb	pb	ADP
ecj-12574	99	44	+	+	NOUN
ecj-12574	99	45	10	10	NUM
ecj-12574	99	46	g	g	NOUN
ecj-12574	99	47	ac	ac	PROPN
ecj-12574	99	48	583	583	PROPN
ecj-12574	99	49	ng	ng	PROPN
ecj-12574	99	50	/	/	SYM
ecj-12574	99	51	ml	ml	PROPN
ecj-12574	99	52	(	(	PUNCT
ecj-12574	99	53	6	6	NUM
ecj-12574	99	54	h	h	NOUN
ecj-12574	99	55	)	)	PUNCT
ecj-12574	99	56	,	,	PUNCT
ecj-12574	99	57	(	(	PUNCT
ecj-12574	99	58	ng	ng	PROPN
ecj-12574	99	59	tube	tube	PROPN
ecj-12574	99	60	)	)	PUNCT
ecj-12574	100	1	+	+	CCONJ
ecj-12574	100	2	oti	oti	PROPN
ecj-12574	100	3	416	416	NUM
ecj-12574	100	4	ng	ng	PROPN
ecj-12574	100	5	/	/	SYM
ecj-12574	100	6	ml	ml	PROPN
ecj-12574	100	7	(	(	PUNCT
ecj-12574	100	8	13	13	NUM
ecj-12574	100	9	h	h	NOUN
ecj-12574	100	10	)	)	PUNCT
ecj-12574	100	11	,	,	PUNCT
ecj-12574	101	1	+	+	CCONJ
ecj-12574	101	2	mdz	mdz	PROPN
ecj-12574	101	3	296	296	NUM
ecj-12574	101	4	ng	ng	PROPN
ecj-12574	101	5	/	/	SYM
ecj-12574	101	6	ml	ml	PROPN
ecj-12574	101	7	(	(	PUNCT
ecj-12574	101	8	23	23	NUM
ecj-12574	101	9	h	h	NOUN
ecj-12574	101	10	)	)	PUNCT
ecj-12574	101	11	,	,	PUNCT
ecj-12574	101	12	janson	janson	PROPN
ecj-12574	101	13	,	,	PUNCT
ecj-12574	101	14	2020¹	2020¹	NUM
ecj-12574	101	15	1	1	NUM
ecj-12574	101	16	1	1	NUM
ecj-12574	101	17	m	m	NOUN
ecj-12574	101	18	m	m	VERB
ecj-12574	101	19	20	20	NUM
ecj-12574	101	20	mg	mg	PROPN
ecj-12574	101	21	77	77	NUM
ecj-12574	101	22	μg	μg	PROPN
ecj-12574	101	23	/	/	SYM
ecj-12574	101	24	l	l	PROPN
ecj-12574	101	25	(	(	PUNCT
ecj-12574	101	26	2	2	NUM
ecj-12574	101	27	h	h	NOUN
ecj-12574	101	28	)	)	PUNCT
ecj-12574	101	29	jitteriness	jitteriness	NOUN
ecj-12574	101	30	,	,	PUNCT
ecj-12574	101	31	↑sbp	↑sbp	NOUN
ecj-12574	101	32	cus	cus	NOUN
ecj-12574	101	33	:	:	PUNCT
ecj-12574	101	34	ac	ac	PROPN
ecj-12574	101	35	,	,	PUNCT
ecj-12574	101	36	↑muscle	↑muscle	NOUN
ecj-12574	101	37	tone	tone	NOUN
ecj-12574	101	38	,	,	PUNCT
ecj-12574	101	39	(	(	PUNCT
ecj-12574	101	40	6	6	NUM
ecj-12574	101	41	mg	mg	NUM
ecj-12574	101	42	/	/	SYM
ecj-12574	101	43	kg	kg	NOUN
ecj-12574	101	44	)	)	PUNCT
ecj-12574	101	45	23	23	NUM
ecj-12574	101	46	μg	μg	PROPN
ecj-12574	101	47	/	/	SYM
ecj-12574	101	48	l	l	PROPN
ecj-12574	101	49	(	(	PUNCT
ecj-12574	101	50	50	50	NUM
ecj-12574	101	51	h	h	NOUN
ecj-12574	101	52	)	)	PUNCT
ecj-12574	101	53	opisthotonos	opisthotonos	PROPN
ecj-12574	101	54	(	(	PUNCT
ecj-12574	101	55	110/38	110/38	PROPN
ecj-12574	101	56	mmhg	mmhg	NOUN
ecj-12574	101	57	)	)	PUNCT
ecj-12574	101	58	normal	normal	ADJ
ecj-12574	101	59	sodium	sodium	NOUN
ecj-12574	101	60	sulfate	sulfate	NOUN
ecj-12574	101	61	ger	ger	NOUN
ecj-12574	101	62	(	(	PUNCT
ecj-12574	101	63	for	for	ADP
ecj-12574	101	64	w	w	NOUN
ecj-12574	101	65	)	)	PUNCT
ecj-12574	101	66	weigl	weigl	NOUN
ecj-12574	101	67	,	,	PUNCT
ecj-12574	101	68	2020¹	2020¹	NUM
ecj-12574	101	69	1	1	NUM
ecj-12574	101	70	14	14	NUM
ecj-12574	101	71	y	y	PROPN
ecj-12574	101	72	f	f	PROPN
ecj-12574	101	73	800	800	NUM
ecj-12574	101	74	mg	mg	PROPN
ecj-12574	101	75	633	633	NUM
ecj-12574	101	76	ng	ng	PROPN
ecj-12574	101	77	/	/	SYM
ecj-12574	101	78	ml	ml	NOUN
ecj-12574	101	79	dizziness	dizziness	NOUN
ecj-12574	101	80	,	,	PUNCT
ecj-12574	101	81	drowsiness	drowsiness	NOUN
ecj-12574	101	82	na	na	NOUN
ecj-12574	101	83	na	na	INTJ
ecj-12574	101	84	ac	ac	PROPN
ecj-12574	101	85	ns	ns	PROPN
ecj-12574	101	86	(	(	PUNCT
ecj-12574	101	87	10.4	10.4	NUM
ecj-12574	101	88	mg	mg	PROPN
ecj-12574	101	89	/	/	SYM
ecj-12574	101	90	kg	kg	NOUN
ecj-12574	101	91	)	)	PUNCT
ecj-12574	101	92	borkar	borkar	NOUN
ecj-12574	101	93	,	,	PUNCT
ecj-12574	101	94	2022¹	2022¹	NUM
ecj-12574	101	95	1	1	NUM
ecj-12574	101	96	7	7	NUM
ecj-12574	101	97	w	w	NOUN
ecj-12574	101	98	m	m	VERB
ecj-12574	101	99	na	na	NOUN
ecj-12574	101	100	na	na	NOUN
ecj-12574	101	101	seizures	seizure	NOUN
ecj-12574	101	102	:	:	PUNCT
ecj-12574	101	103	intermittent	intermittent	ADJ
ecj-12574	101	104	normal	normal	ADJ
ecj-12574	101	105	mdz	mdz	PROPN
ecj-12574	101	106	(	(	PUNCT
ecj-12574	101	107	0.1	0.1	NUM
ecj-12574	101	108	mg	mg	PROPN
ecj-12574	101	109	/	/	SYM
ecj-12574	101	110	kg	kg	NOUN
ecj-12574	101	111	)	)	PUNCT
ecj-12574	101	112	at	at	ADP
ecj-12574	101	113	2	2	NUM
ecj-12574	101	114	year	year	NOUN
ecj-12574	101	115	fu	fu	NOUN
ecj-12574	101	116	:	:	PUNCT
ecj-12574	101	117	intense	intense	ADJ
ecj-12574	101	118	cry	cry	NOUN
ecj-12574	101	119	,	,	PUNCT
ecj-12574	101	120	tachycardia	tachycardia	NOUN
ecj-12574	101	121	,	,	PUNCT
ecj-12574	101	122	mild	mild	ADJ
ecj-12574	101	123	speech	speech	NOUN
ecj-12574	101	124	delay	delay	NOUN
ecj-12574	101	125	extension	extension	NOUN
ecj-12574	101	126	of	of	ADP
ecj-12574	101	127	hypertension	hypertension	NOUN
ecj-12574	101	128	both	both	DET
ecj-12574	101	129	arms	arm	NOUN
ecj-12574	101	130	,	,	PUNCT
ecj-12574	101	131	clenching	clench	VERB
ecj-12574	101	132	of	of	ADP
ecj-12574	101	133	the	the	DET
ecj-12574	101	134	fists	fist	NOUN
ecj-12574	101	135	,	,	PUNCT
ecj-12574	101	136	facial	facial	ADJ
ecj-12574	101	137	redness	redness	NOUN
ecj-12574	101	138	,	,	PUNCT
ecj-12574	101	139	eye	eye	NOUN
ecj-12574	101	140	deviation	deviation	NOUN
ecj-12574	101	141	to	to	ADP
ecj-12574	101	142	the	the	DET
ecj-12574	101	143	left	left	ADJ
ecj-12574	101	144	,	,	PUNCT
ecj-12574	101	145	nystagmus	nystagmus	ADJ
ecj-12574	101	146	,	,	PUNCT
ecj-12574	101	147	mydriasis	mydriasis	NOUN
ecj-12574	101	148	,	,	PUNCT
ecj-12574	101	149	absence	absence	NOUN
ecj-12574	101	150	of	of	ADP
ecj-12574	101	151	visual	visual	ADJ
ecj-12574	101	152	tracking	tracking	NOUN
ecj-12574	101	153	.	.	PUNCT
ecj-12574	102	1	neck	neck	NOUN
ecj-12574	102	2	,	,	PUNCT
ecj-12574	102	3	arms	arm	NOUN
ecj-12574	102	4	and	and	CCONJ
ecj-12574	102	5	legs	leg	NOUN
ecj-12574	102	6	hypertonic	hypertonic	ADJ
ecj-12574	102	7	flexion	flexion	NOUN
ecj-12574	102	8	legend	legend	NOUN
ecj-12574	102	9	:	:	PUNCT
ecj-12574	102	10	ac	ac	PROPN
ecj-12574	102	11	,	,	PUNCT
ecj-12574	102	12	activated	activate	VERB
ecj-12574	102	13	charcoal	charcoal	NOUN
ecj-12574	102	14	,	,	PUNCT
ecj-12574	102	15	cus	cus	NOUN
ecj-12574	102	16	,	,	PUNCT
ecj-12574	102	17	cranial	cranial	ADJ
ecj-12574	102	18	ultrasound	ultrasound	NOUN
ecj-12574	102	19	,	,	PUNCT
ecj-12574	102	20	fu	fu	NOUN
ecj-12574	102	21	,	,	PUNCT
ecj-12574	102	22	follow	follow	NOUN
ecj-12574	102	23	-	-	PUNCT
ecj-12574	102	24	up	up	NOUN
ecj-12574	102	25	,	,	PUNCT
ecj-12574	102	26	ger	ger	NOUN
ecj-12574	102	27	,	,	PUNCT
ecj-12574	102	28	gastro	gastro	NOUN
ecj-12574	102	29	-	-	PUNCT
ecj-12574	102	30	esophageal	esophageal	NOUN
ecj-12574	102	31	reflux	reflux	NOUN
ecj-12574	102	32	,	,	PUNCT
ecj-12574	102	33	mdz	mdz	PROPN
ecj-12574	102	34	,	,	PUNCT
ecj-12574	102	35	midazolam	midazolam	PROPN
ecj-12574	102	36	,	,	PUNCT
ecj-12574	102	37	na	na	PROPN
ecj-12574	102	38	,	,	PUNCT
ecj-12574	102	39	non	non	X
ecj-12574	102	40	available	available	ADJ
ecj-12574	102	41	,	,	PUNCT
ecj-12574	102	42	n	n	CCONJ
ecj-12574	102	43	,	,	PUNCT
ecj-12574	102	44	number	number	NOUN
ecj-12574	102	45	,	,	PUNCT
ecj-12574	102	46	ns	ns	INTJ
ecj-12574	102	47	,	,	PUNCT
ecj-12574	102	48	no	no	DET
ecj-12574	102	49	sequelae	sequelae	PROPN
ecj-12574	102	50	,	,	PUNCT
ecj-12574	102	51	oti	oti	PROPN
ecj-12574	102	52	,	,	PUNCT
ecj-12574	102	53	orotracheal	orotracheal	ADJ
ecj-12574	102	54	intubation	intubation	NOUN
ecj-12574	102	55	,	,	PUNCT
ecj-12574	102	56	pb	pb	CCONJ
ecj-12574	102	57	,	,	PUNCT
ecj-12574	102	58	phenobarbital	phenobarbital	ADJ
ecj-12574	102	59	,	,	PUNCT
ecj-12574	102	60	pht	pht	PROPN
ecj-12574	102	61	,	,	PUNCT
ecj-12574	102	62	fosphenytoin	fosphenytoin	PROPN
ecj-12574	102	63	,	,	PUNCT
ecj-12574	102	64	pt	pt	NOUN
ecj-12574	102	65	,	,	PUNCT
ecj-12574	102	66	patients	patient	NOUN
ecj-12574	102	67	;	;	PUNCT
ecj-12574	102	68	sbp	sbp	NOUN
ecj-12574	102	69	,	,	PUNCT
ecj-12574	102	70	sistolic	sistolic	ADJ
ecj-12574	102	71	blood	blood	NOUN
ecj-12574	102	72	pressure	pressure	NOUN
ecj-12574	102	73	,	,	PUNCT
ecj-12574	102	74	tc	tc	NOUN
ecj-12574	102	75	,	,	PUNCT
ecj-12574	102	76	tonic	tonic	NOUN
ecj-12574	102	77	-	-	PUNCT
ecj-12574	102	78	clonic	clonic	NOUN
ecj-12574	102	79	.	.	PUNCT
ecj-12574	103	1	non	non	PROPN
ecj-12574	104	1	-co	-co	PROPN
ecj-12574	104	2	mmerc	mmerc	PROPN
ecj-12574	104	3	ial	ial	PROPN
ecj-12574	104	4	us	us	PROPN
ecj-12574	104	5	e	e	NOUN
ecj-12574	104	6	o	o	NOUN
ecj-12574	104	7	nly	nly	ADV
ecj-12574	104	8	references	reference	NOUN
ecj-12574	104	9	1	1	NUM
ecj-12574	104	10	.	.	PUNCT
ecj-12574	105	1	javad	javad	PROPN
ecj-12574	105	2	alaghband	alaghband	PROPN
ecj-12574	105	3	-	-	PUNCT
ecj-12574	105	4	rad	rad	PROPN
ecj-12574	105	5	mh	mh	PROPN
ecj-12574	105	6	.	.	PUNCT
ecj-12574	106	1	a	a	DET
ecj-12574	106	2	randomized	randomized	ADJ
ecj-12574	106	3	controlled	control	VERB
ecj-12574	106	4	clinical	clinical	ADJ
ecj-12574	106	5	trial	trial	NOUN
ecj-12574	106	6	of	of	ADP
ecj-12574	106	7	citalopram	citalopram	PROPN
ecj-12574	106	8	versus	versus	ADP
ecj-12574	106	9	fluoxetine	fluoxetine	NOUN
ecj-12574	106	10	in	in	ADP
ecj-12574	106	11	children	child	NOUN
ecj-12574	106	12	and	and	CCONJ
ecj-12574	106	13	adolescents	adolescent	NOUN
ecj-12574	106	14	with	with	ADP
ecj-12574	106	15	obsessive	obsessive	ADJ
ecj-12574	106	16	-	-	PUNCT
ecj-12574	106	17	compulsive	compulsive	ADJ
ecj-12574	106	18	disorder	disorder	NOUN
ecj-12574	106	19	(	(	PUNCT
ecj-12574	106	20	ocd	ocd	NOUN
ecj-12574	106	21	)	)	PUNCT
ecj-12574	106	22	.	.	PUNCT
ecj-12574	107	1	eur	eur	PROPN
ecj-12574	107	2	child	child	PROPN
ecj-12574	107	3	adolesc	adolesc	PROPN
ecj-12574	107	4	psychiatry	psychiatry	PROPN
ecj-12574	107	5	2009;183:131–5	2009;183:131–5	PROPN
ecj-12574	107	6	.	.	PUNCT
ecj-12574	108	1	2	2	NUM
ecj-12574	108	2	.	.	X
ecj-12574	108	3	cipriani	cipriani	PROPN
ecj-12574	108	4	a	a	PROPN
ecj-12574	108	5	,	,	PUNCT
ecj-12574	108	6	zhou	zhou	PROPN
ecj-12574	108	7	x	x	PROPN
ecj-12574	108	8	,	,	PUNCT
ecj-12574	108	9	del	del	X
ecj-12574	108	10	giovane	giovane	PROPN
ecj-12574	108	11	c	c	PROPN
ecj-12574	108	12	,	,	PUNCT
ecj-12574	108	13	et	et	PROPN
ecj-12574	108	14	al	al	PROPN
ecj-12574	108	15	.	.	PROPN
ecj-12574	108	16	comparative	comparative	ADJ
ecj-12574	108	17	efficacy	efficacy	NOUN
ecj-12574	108	18	and	and	CCONJ
ecj-12574	108	19	tolerability	tolerability	NOUN
ecj-12574	108	20	of	of	ADP
ecj-12574	108	21	antidepressants	antidepressant	NOUN
ecj-12574	108	22	for	for	ADP
ecj-12574	108	23	major	major	ADJ
ecj-12574	108	24	depressive	depressive	ADJ
ecj-12574	108	25	disorder	disorder	NOUN
ecj-12574	108	26	in	in	ADP
ecj-12574	108	27	children	child	NOUN
ecj-12574	108	28	and	and	CCONJ
ecj-12574	108	29	adolescents	adolescent	NOUN
ecj-12574	108	30	:	:	PUNCT
ecj-12574	108	31	a	a	DET
ecj-12574	108	32	network	network	NOUN
ecj-12574	108	33	meta	meta	NOUN
ecj-12574	108	34	-	-	PUNCT
ecj-12574	108	35	analysis	analysis	NOUN
ecj-12574	108	36	.	.	PUNCT
ecj-12574	109	1	lancet	lancet	PROPN
ecj-12574	109	2	2016;388:881	2016;388:881	NUM
ecj-12574	109	3	-	-	SYM
ecj-12574	109	4	90	90	NUM
ecj-12574	109	5	.	.	PUNCT
ecj-12574	110	1	3	3	X
ecj-12574	110	2	.	.	X
ecj-12574	110	3	bezchlibnyk	bezchlibnyk	ADJ
ecj-12574	110	4	-	-	PUNCT
ecj-12574	110	5	butler	butler	NOUN
ecj-12574	110	6	k	k	PROPN
ecj-12574	110	7	,	,	PUNCT
ecj-12574	110	8	aleksic	aleksic	PROPN
ecj-12574	110	9	i	i	PROPN
ecj-12574	110	10	,	,	PUNCT
ecj-12574	110	11	kennedy	kennedy	PROPN
ecj-12574	110	12	sh	sh	PROPN
ecj-12574	110	13	.	.	PROPN
ecj-12574	110	14	citalopram	citalopram	PROPN
ecj-12574	111	1	a	a	DET
ecj-12574	111	2	review	review	NOUN
ecj-12574	111	3	of	of	ADP
ecj-12574	111	4	pharmacological	pharmacological	ADJ
ecj-12574	111	5	and	and	CCONJ
ecj-12574	111	6	clinical	clinical	ADJ
ecj-12574	111	7	effects	effect	NOUN
ecj-12574	111	8	.	.	PUNCT
ecj-12574	112	1	j	j	PROPN
ecj-12574	112	2	psychiatry	psychiatry	PROPN
ecj-12574	112	3	neurosci	neurosci	PROPN
ecj-12574	112	4	2000;25:241–54	2000;25:241–54	PROPN
ecj-12574	112	5	.	.	PROPN
ecj-12574	112	6	4	4	NUM
ecj-12574	112	7	.	.	X
ecj-12574	112	8	personne	personne	PROPN
ecj-12574	112	9	m	m	PROPN
ecj-12574	112	10	,	,	PUNCT
ecj-12574	112	11	sjöberg	sjöberg	PROPN
ecj-12574	112	12	g	g	PROPN
ecj-12574	112	13	,	,	PUNCT
ecj-12574	112	14	persson	persson	PROPN
ecj-12574	112	15	h.	h.	PROPN
ecj-12574	112	16	citalopram	citalopram	PROPN
ecj-12574	112	17	overdose	overdose	PROPN
ecj-12574	112	18	review	review	PROPN
ecj-12574	112	19	of	of	ADP
ecj-12574	112	20	cases	case	NOUN
ecj-12574	112	21	treated	treat	VERB
ecj-12574	112	22	in	in	ADP
ecj-12574	112	23	swedish	swedish	ADJ
ecj-12574	112	24	hospitals	hospital	NOUN
ecj-12574	112	25	.	.	PUNCT
ecj-12574	113	1	j	j	PROPN
ecj-12574	113	2	toxicol	toxicol	PROPN
ecj-12574	113	3	clin	clin	PROPN
ecj-12574	113	4	toxicol	toxicol	PROPN
ecj-12574	113	5	1997;35:237–40	1997;35:237–40	X
ecj-12574	113	6	.	.	PROPN
ecj-12574	114	1	5	5	NUM
ecj-12574	114	2	.	.	X
ecj-12574	114	3	klein	klein	PROPN
ecj-12574	114	4	-	-	PUNCT
ecj-12574	114	5	schwartz	schwartz	PROPN
ecj-12574	114	6	w	w	PROPN
ecj-12574	114	7	,	,	PUNCT
ecj-12574	114	8	benson	benson	PROPN
ecj-12574	114	9	be	be	PROPN
ecj-12574	114	10	,	,	PUNCT
ecj-12574	114	11	lee	lee	PROPN
ecj-12574	114	12	sc	sc	PROPN
ecj-12574	114	13	,	,	PUNCT
ecj-12574	114	14	litovitz	litovitz	PROPN
ecj-12574	114	15	t.	t.	PROPN
ecj-12574	114	16	comparison	comparison	NOUN
ecj-12574	114	17	of	of	ADP
ecj-12574	114	18	citalopram	citalopram	PROPN
ecj-12574	114	19	and	and	CCONJ
ecj-12574	114	20	other	other	ADJ
ecj-12574	114	21	selective	selective	ADJ
ecj-12574	114	22	serotonin	serotonin	NOUN
ecj-12574	114	23	reuptake	reuptake	NOUN
ecj-12574	114	24	inhibitor	inhibitor	NOUN
ecj-12574	114	25	ingestions	ingestion	NOUN
ecj-12574	114	26	in	in	ADP
ecj-12574	114	27	children	child	NOUN
ecj-12574	114	28	.	.	PUNCT
ecj-12574	115	1	clin	clin	PROPN
ecj-12574	115	2	toxicol	toxicol	PROPN
ecj-12574	115	3	2012;50:418–23	2012;50:418–23	PROPN
ecj-12574	115	4	.	.	PROPN
ecj-12574	115	5	6	6	NUM
ecj-12574	115	6	.	.	X
ecj-12574	115	7	ducros	ducro	NOUN
ecj-12574	116	1	a	a	PRON
ecj-12574	116	2	,	,	PUNCT
ecj-12574	116	3	boukobza	boukobza	NOUN
ecj-12574	116	4	m	m	PROPN
ecj-12574	116	5	,	,	PUNCT
ecj-12574	116	6	porcher	porcher	PROPN
ecj-12574	116	7	r	r	PROPN
ecj-12574	116	8	,	,	PUNCT
ecj-12574	116	9	et	et	PROPN
ecj-12574	116	10	al	al	PROPN
ecj-12574	116	11	.	.	PUNCT
ecj-12574	117	1	the	the	DET
ecj-12574	117	2	clinical	clinical	ADJ
ecj-12574	117	3	and	and	CCONJ
ecj-12574	117	4	radiological	radiological	ADJ
ecj-12574	117	5	spectrum	spectrum	NOUN
ecj-12574	117	6	of	of	ADP
ecj-12574	117	7	reversible	reversible	ADJ
ecj-12574	117	8	cerebral	cerebral	ADJ
ecj-12574	117	9	vasoconstriction	vasoconstriction	NOUN
ecj-12574	117	10	syndrome	syndrome	NOUN
ecj-12574	117	11	.	.	PUNCT
ecj-12574	118	1	a	a	DET
ecj-12574	118	2	prospective	prospective	ADJ
ecj-12574	118	3	series	series	NOUN
ecj-12574	118	4	of	of	ADP
ecj-12574	118	5	67	67	NUM
ecj-12574	118	6	patients	patient	NOUN
ecj-12574	118	7	.	.	PUNCT
ecj-12574	119	1	brain	brain	NOUN
ecj-12574	119	2	2007;130:3091–101	2007;130:3091–101	PROPN
ecj-12574	119	3	.	.	PUNCT
ecj-12574	120	1	7	7	X
ecj-12574	120	2	.	.	X
ecj-12574	120	3	prakash	prakash	PROPN
ecj-12574	120	4	s	s	PROPN
ecj-12574	120	5	,	,	PUNCT
ecj-12574	120	6	rathore	rathore	PROPN
ecj-12574	120	7	c	c	PROPN
ecj-12574	120	8	,	,	PUNCT
ecj-12574	120	9	kaushikkumar	kaushikkumar	PROPN
ecj-12574	120	10	r.	r.	PROPN
ecj-12574	120	11	posterior	posterior	PROPN
ecj-12574	120	12	reversible	reversible	ADJ
ecj-12574	120	13	encephalopathy	encephalopathy	ADJ
ecj-12574	120	14	syndrome	syndrome	NOUN
ecj-12574	120	15	in	in	ADP
ecj-12574	120	16	a	a	DET
ecj-12574	120	17	patient	patient	NOUN
ecj-12574	120	18	with	with	ADP
ecj-12574	120	19	serotonin	serotonin	NOUN
ecj-12574	120	20	syndrome	syndrome	NOUN
ecj-12574	120	21	.	.	PUNCT
ecj-12574	121	1	bmj	bmj	PROPN
ecj-12574	121	2	case	case	NOUN
ecj-12574	121	3	rep	rep	PROPN
ecj-12574	121	4	2020;13	2020;13	NOUN
ecj-12574	121	5	:	:	PUNCT
ecj-12574	121	6	e236450	e236450	ADJ
ecj-12574	121	7	.	.	NOUN
ecj-12574	121	8	8	8	X
ecj-12574	121	9	.	.	X
ecj-12574	121	10	bhutada	bhutada	PROPN
ecj-12574	121	11	as	as	ADP
ecj-12574	121	12	,	,	PUNCT
ecj-12574	121	13	kodankandath	kodankandath	PROPN
ecj-12574	121	14	tv	tv	PROPN
ecj-12574	121	15	.	.	PUNCT
ecj-12574	121	16	delayed	delay	VERB
ecj-12574	121	17	presentation	presentation	NOUN
ecj-12574	121	18	of	of	ADP
ecj-12574	121	19	posterior	posterior	ADJ
ecj-12574	121	20	reversible	reversible	ADJ
ecj-12574	121	21	encephalopathy	encephalopathy	ADJ
ecj-12574	121	22	syndrome	syndrome	NOUN
ecj-12574	121	23	in	in	ADP
ecj-12574	121	24	the	the	DET
ecj-12574	121	25	setting	setting	NOUN
ecj-12574	121	26	of	of	ADP
ecj-12574	121	27	serotonin	serotonin	NOUN
ecj-12574	121	28	-	-	PUNCT
ecj-12574	121	29	norepinephrine	norepinephrine	NOUN
ecj-12574	121	30	reuptake	reuptake	NOUN
ecj-12574	121	31	inhibitors	inhibitor	NOUN
ecj-12574	121	32	.	.	PUNCT
ecj-12574	122	1	cureus	cureus	PROPN
ecj-12574	122	2	2022;14	2022;14	NUM
ecj-12574	122	3	:	:	PUNCT
ecj-12574	122	4	e22454	e22454	NOUN
ecj-12574	122	5	.	.	PUNCT
ecj-12574	123	1	9	9	NUM
ecj-12574	123	2	.	.	X
ecj-12574	123	3	malik	malik	PROPN
ecj-12574	123	4	mt	mt	PROPN
ecj-12574	123	5	,	,	PUNCT
ecj-12574	123	6	majeed	majeed	PROPN
ecj-12574	123	7	mf	mf	PROPN
ecj-12574	123	8	,	,	PUNCT
ecj-12574	123	9	zand	zand	PROPN
ecj-12574	123	10	r.	r.	PROPN
ecj-12574	123	11	serotonin	serotonin	VERB
ecj-12574	123	12	syndrome	syndrome	NOUN
ecj-12574	123	13	presenting	present	VERB
ecj-12574	123	14	as	as	ADP
ecj-12574	123	15	a	a	DET
ecj-12574	123	16	posterior	posterior	ADJ
ecj-12574	123	17	reversible	reversible	ADJ
ecj-12574	123	18	encephalopathy	encephalopathy	ADJ
ecj-12574	123	19	syndrome	syndrome	NOUN
ecj-12574	123	20	.	.	PUNCT
ecj-12574	124	1	case	case	NOUN
ecj-12574	124	2	rep	rep	PROPN
ecj-12574	124	3	neurol	neurol	PROPN
ecj-12574	124	4	2020;12:63–8	2020;12:63–8	PROPN
ecj-12574	124	5	.	.	PROPN
ecj-12574	124	6	10	10	NUM
ecj-12574	124	7	.	.	PUNCT
ecj-12574	125	1	tormoehlen	tormoehlen	PROPN
ecj-12574	125	2	lm	lm	PROPN
ecj-12574	125	3	,	,	PUNCT
ecj-12574	125	4	rusyniak	rusyniak	PROPN
ecj-12574	125	5	de	de	X
ecj-12574	125	6	.	.	PROPN
ecj-12574	125	7	neuroleptic	neuroleptic	ADJ
ecj-12574	125	8	malignant	malignant	ADJ
ecj-12574	125	9	syndrome	syndrome	NOUN
ecj-12574	125	10	and	and	CCONJ
ecj-12574	125	11	serotonin	serotonin	VERB
ecj-12574	125	12	syndrome	syndrome	NOUN
ecj-12574	125	13	.	.	PUNCT
ecj-12574	126	1	1st	1st	ADJ
ecj-12574	126	2	ed	ed	NOUN
ecj-12574	126	3	.	.	PUNCT
ecj-12574	126	4	vol	vol	NOUN
ecj-12574	126	5	.	.	PROPN
ecj-12574	127	1	157	157	NUM
ecj-12574	127	2	,	,	PUNCT
ecj-12574	127	3	handbook	handbook	NOUN
ecj-12574	127	4	of	of	ADP
ecj-12574	127	5	clinical	clinical	ADJ
ecj-12574	127	6	neurology	neurology	NOUN
ecj-12574	127	7	.	.	PUNCT
ecj-12574	128	1	elsevier	elsevier	PROPN
ecj-12574	128	2	b.v	b.v	PROPN
ecj-12574	128	3	.	.	PROPN
ecj-12574	128	4	;	;	PUNCT
ecj-12574	128	5	2018	2018	NUM
ecj-12574	128	6	.	.	PUNCT
ecj-12574	129	1	663–675	663–675	NUM
ecj-12574	129	2	p.	p.	NOUN
ecj-12574	129	3	11	11	NUM
ecj-12574	129	4	.	.	PUNCT
ecj-12574	130	1	page	page	NOUN
ecj-12574	130	2	mj	mj	PROPN
ecj-12574	130	3	,	,	PUNCT
ecj-12574	130	4	mckenzie	mckenzie	PROPN
ecj-12574	130	5	je	je	PROPN
ecj-12574	130	6	,	,	PUNCT
ecj-12574	130	7	bossuyt	bossuyt	NOUN
ecj-12574	130	8	pm	pm	NOUN
ecj-12574	130	9	,	,	PUNCT
ecj-12574	130	10	et	et	PROPN
ecj-12574	130	11	al	al	PROPN
ecj-12574	130	12	.	.	PUNCT
ecj-12574	131	1	the	the	DET
ecj-12574	131	2	prisma	prisma	PROPN
ecj-12574	131	3	2020	2020	NUM
ecj-12574	131	4	statement	statement	NOUN
ecj-12574	131	5	:	:	PUNCT
ecj-12574	131	6	an	an	DET
ecj-12574	131	7	updated	update	VERB
ecj-12574	131	8	guideline	guideline	NOUN
ecj-12574	131	9	for	for	ADP
ecj-12574	131	10	reporting	report	VERB
ecj-12574	131	11	systematic	systematic	ADJ
ecj-12574	131	12	reviews	review	NOUN
ecj-12574	131	13	.	.	PUNCT
ecj-12574	132	1	bmj	bmj	PROPN
ecj-12574	132	2	2021;372	2021;372	NUM
ecj-12574	132	3	:	:	PUNCT
ecj-12574	132	4	n71	n71	ADJ
ecj-12574	132	5	.	.	PUNCT
ecj-12574	133	1	12	12	NUM
ecj-12574	133	2	.	.	PUNCT
ecj-12574	134	1	rethlefsen	rethlefsen	PROPN
ecj-12574	134	2	ml	ml	PROPN
ecj-12574	134	3	,	,	PUNCT
ecj-12574	134	4	kirtley	kirtley	PROPN
ecj-12574	134	5	s	s	PROPN
ecj-12574	134	6	,	,	PUNCT
ecj-12574	134	7	waffenschmidt	waffenschmidt	PROPN
ecj-12574	134	8	s	s	PROPN
ecj-12574	134	9	,	,	PUNCT
ecj-12574	134	10	et	et	PROPN
ecj-12574	134	11	al	al	PROPN
ecj-12574	134	12	.	.	PUNCT
ecj-12574	134	13	prisma	prisma	PROPN
ecj-12574	134	14	-	-	PUNCT
ecj-12574	134	15	s	s	PROPN
ecj-12574	134	16	:	:	PUNCT
ecj-12574	134	17	an	an	DET
ecj-12574	134	18	extension	extension	NOUN
ecj-12574	134	19	to	to	ADP
ecj-12574	134	20	the	the	DET
ecj-12574	134	21	prisma	prisma	NOUN
ecj-12574	134	22	statement	statement	NOUN
ecj-12574	134	23	for	for	ADP
ecj-12574	134	24	reporting	report	VERB
ecj-12574	134	25	literature	literature	NOUN
ecj-12574	134	26	searches	search	NOUN
ecj-12574	134	27	in	in	ADP
ecj-12574	134	28	systematic	systematic	ADJ
ecj-12574	134	29	reviews	review	NOUN
ecj-12574	134	30	.	.	PUNCT
ecj-12574	135	1	syst	syst	PROPN
ecj-12574	135	2	rev	rev	PROPN
ecj-12574	135	3	2021;10:39	2021;10:39	NUM
ecj-12574	135	4	.	.	PROPN
ecj-12574	136	1	13	13	NUM
ecj-12574	136	2	.	.	PUNCT
ecj-12574	137	1	masullo	masullo	PROPN
ecj-12574	137	2	l	l	PROPN
ecj-12574	137	3	,	,	PUNCT
ecj-12574	137	4	miller	miller	PROPN
ecj-12574	137	5	m	m	PROPN
ecj-12574	137	6	,	,	PUNCT
ecj-12574	137	7	baker	baker	PROPN
ecj-12574	137	8	sd	sd	PROPN
ecj-12574	137	9	,	,	PUNCT
ecj-12574	137	10	et	et	PROPN
ecj-12574	137	11	al	al	PROPN
ecj-12574	137	12	.	.	PUNCT
ecj-12574	138	1	clinical	clinical	ADJ
ecj-12574	138	2	course	course	NOUN
ecj-12574	138	3	and	and	CCONJ
ecj-12574	138	4	toxicokinetic	toxicokinetic	ADJ
ecj-12574	138	5	data	datum	NOUN
ecj-12574	138	6	following	follow	VERB
ecj-12574	138	7	isolated	isolate	VERB
ecj-12574	138	8	citalopram	citalopram	PROPN
ecj-12574	138	9	overdose	overdose	NOUN
ecj-12574	138	10	in	in	ADP
ecj-12574	138	11	an	an	DET
ecj-12574	138	12	infant	infant	NOUN
ecj-12574	138	13	.	.	PUNCT
ecj-12574	139	1	clin	clin	PROPN
ecj-12574	139	2	toxicol	toxicol	PROPN
ecj-12574	139	3	2006;44:165–8	2006;44:165–8	NUM
ecj-12574	139	4	.	.	PUNCT
ecj-12574	140	1	14	14	NUM
ecj-12574	140	2	.	.	PUNCT
ecj-12574	141	1	janson	janson	PROPN
ecj-12574	141	2	ja	ja	PROPN
ecj-12574	141	3	,	,	PUNCT
ecj-12574	141	4	wasylewicz	wasylewicz	PROPN
ecj-12574	141	5	atm	atm	PROPN
ecj-12574	141	6	,	,	PUNCT
ecj-12574	141	7	eijkemans	eijkeman	VERB
ecj-12574	141	8	m	m	PROPN
ecj-12574	141	9	,	,	PUNCT
ecj-12574	141	10	et	et	PROPN
ecj-12574	141	11	al	al	PROPN
ecj-12574	141	12	.	.	PROPN
ecj-12574	141	13	citalopram	citalopram	PROPN
ecj-12574	141	14	intoxication	intoxication	NOUN
ecj-12574	141	15	in	in	ADP
ecj-12574	141	16	four	four	NUM
ecj-12574	141	17	week	week	NOUN
ecj-12574	141	18	old	old	ADJ
ecj-12574	141	19	infant	infant	NOUN
ecj-12574	141	20	.	.	PUNCT
ecj-12574	142	1	bmc	bmc	VERB
ecj-12574	142	2	pediatr	pediatr	ADJ
ecj-12574	142	3	2020;20:1	2020;20:1	PROPN
ecj-12574	142	4	–	–	PUNCT
ecj-12574	142	5	5	5	NUM
ecj-12574	142	6	.	.	SYM
ecj-12574	142	7	15	15	NUM
ecj-12574	142	8	.	.	PUNCT
ecj-12574	143	1	weigl	weigl	PROPN
ecj-12574	143	2	j	j	PROPN
ecj-12574	143	3	,	,	PUNCT
ecj-12574	143	4	vloet	vloet	PROPN
ecj-12574	143	5	t	t	PROPN
ecj-12574	143	6	,	,	PUNCT
ecj-12574	143	7	egberts	egberts	PROPN
ecj-12574	143	8	k	k	PROPN
ecj-12574	143	9	,	,	PUNCT
ecj-12574	143	10	et	et	PROPN
ecj-12574	143	11	al	al	PROPN
ecj-12574	143	12	.	.	PUNCT
ecj-12574	144	1	non	non	ADJ
ecj-12574	144	2	-	-	ADJ
ecj-12574	144	3	fatal	fatal	ADJ
ecj-12574	144	4	intoxication	intoxication	NOUN
ecj-12574	144	5	with	with	ADP
ecj-12574	144	6	a	a	DET
ecj-12574	144	7	high	high	ADJ
ecj-12574	144	8	dose	dose	NOUN
ecj-12574	144	9	of	of	ADP
ecj-12574	144	10	citalopram	citalopram	PROPN
ecj-12574	144	11	in	in	ADP
ecj-12574	144	12	a	a	DET
ecj-12574	144	13	suicidal	suicidal	ADJ
ecj-12574	144	14	14	14	NUM
ecj-12574	144	15	-	-	PUNCT
ecj-12574	144	16	year	year	NOUN
ecj-12574	144	17	-	-	PUNCT
ecj-12574	144	18	old	old	ADJ
ecj-12574	144	19	girl	girl	NOUN
ecj-12574	144	20	.	.	PUNCT
ecj-12574	145	1	z	z	NOUN
ecj-12574	145	2	kinder	kind	ADJ
ecj-12574	145	3	jugendpsychiatr	jugendpsychiatr	VERB
ecj-12574	145	4	psychother	psychother	ADJ
ecj-12574	145	5	2019;47:168–70	2019;47:168–70	PROPN
ecj-12574	145	6	.	.	PUNCT
ecj-12574	146	1	16	16	NUM
ecj-12574	146	2	.	.	PUNCT
ecj-12574	147	1	borkar	borkar	PROPN
ecj-12574	148	1	d	d	X
ecj-12574	148	2	,	,	PUNCT
ecj-12574	148	3	kiragub	kiragub	PROPN
ecj-12574	148	4	a	a	DET
ecj-12574	148	5	w	w	PROPN
ecj-12574	148	6	,	,	PUNCT
ecj-12574	148	7	arensc	arensc	ADV
ecj-12574	148	8	a	a	X
ecj-12574	148	9	,	,	PUNCT
ecj-12574	148	10	montaguec	montaguec	ADV
ecj-12574	148	11	a	a	DET
ecj-12574	148	12	j.	j.	PROPN
ecj-12574	148	13	a	a	DET
ecj-12574	148	14	7	7	NUM
ecj-12574	148	15	-	-	PUNCT
ecj-12574	148	16	weekold	weekold	ADJ
ecj-12574	148	17	infant	infant	NOUN
ecj-12574	148	18	with	with	ADP
ecj-12574	148	19	serotonin	serotonin	NOUN
ecj-12574	148	20	syndrome	syndrome	NOUN
ecj-12574	148	21	.	.	PUNCT
ecj-12574	149	1	north	north	NOUN
ecj-12574	149	2	american	american	PROPN
ecj-12574	149	3	congress	congress	PROPN
ecj-12574	149	4	of	of	ADP
ecj-12574	149	5	clinical	clinical	ADJ
ecj-12574	149	6	toxicology	toxicology	NOUN
ecj-12574	149	7	(	(	PUNCT
ecj-12574	149	8	nacct	nacct	NOUN
ecj-12574	149	9	)	)	PUNCT
ecj-12574	149	10	2022	2022	NUM
ecj-12574	149	11	.	.	PUNCT
ecj-12574	150	1	clin	clin	PROPN
ecj-12574	150	2	toxicol	toxicol	PROPN
ecj-12574	150	3	2022;60:1–162	2022;60:1–162	NOUN
ecj-12574	150	4	.	.	PUNCT
ecj-12574	151	1	17	17	NUM
ecj-12574	151	2	.	.	NOUN
ecj-12574	151	3	schult	schult	PROPN
ecj-12574	151	4	rf	rf	NOUN
ecj-12574	151	5	,	,	PUNCT
ecj-12574	151	6	morris	morris	PROPN
ecj-12574	151	7	aj	aj	PROPN
ecj-12574	151	8	,	,	PUNCT
ecj-12574	151	9	picard	picard	PROPN
ecj-12574	151	10	l	l	PROPN
ecj-12574	151	11	,	,	PUNCT
ecj-12574	151	12	et	et	PROPN
ecj-12574	151	13	al	al	PROPN
ecj-12574	151	14	.	.	PROPN
ecj-12574	151	15	citalopram	citalopram	PROPN
ecj-12574	151	16	overdose	overdose	PROPN
ecj-12574	151	17	and	and	CCONJ
ecj-12574	151	18	severe	severe	ADJ
ecj-12574	151	19	serotonin	serotonin	NOUN
ecj-12574	151	20	syndrome	syndrome	NOUN
ecj-12574	151	21	in	in	ADP
ecj-12574	151	22	an	an	DET
ecj-12574	151	23	intermediate	intermediate	ADJ
ecj-12574	151	24	metabolizing	metabolize	VERB
ecj-12574	151	25	patient	patient	NOUN
ecj-12574	151	26	.	.	PUNCT
ecj-12574	152	1	am	be	AUX
ecj-12574	152	2	j	j	PROPN
ecj-12574	152	3	emerg	emerg	PROPN
ecj-12574	152	4	med	med	PROPN
ecj-12574	152	5	2019;37:1993.e5	2019;37:1993.e5	PROPN
ecj-12574	152	6	-	-	PUNCT
ecj-12574	152	7	1993.e6	1993.e6	NOUN
ecj-12574	152	8	.	.	PROPN
ecj-12574	152	9	18	18	NUM
ecj-12574	152	10	.	.	PUNCT
ecj-12574	153	1	prakash	prakash	PROPN
ecj-12574	153	2	s	s	PROPN
ecj-12574	153	3	,	,	PUNCT
ecj-12574	153	4	rathore	rathore	PROPN
ecj-12574	153	5	c	c	PROPN
ecj-12574	153	6	,	,	PUNCT
ecj-12574	153	7	rana	rana	PROPN
ecj-12574	153	8	k	k	PROPN
ecj-12574	153	9	,	,	PUNCT
ecj-12574	153	10	patel	patel	PROPN
ecj-12574	153	11	h.	h.	PROPN
ecj-12574	153	12	antiepileptic	antiepileptic	ADJ
ecj-12574	153	13	drugs	drug	NOUN
ecj-12574	153	14	and	and	CCONJ
ecj-12574	153	15	serotonin	serotonin	VERB
ecj-12574	153	16	syndrome	syndrome	NOUN
ecj-12574	153	17	a	a	DET
ecj-12574	153	18	systematic	systematic	ADJ
ecj-12574	153	19	review	review	NOUN
ecj-12574	153	20	of	of	ADP
ecj-12574	153	21	case	case	NOUN
ecj-12574	153	22	series	series	NOUN
ecj-12574	153	23	and	and	CCONJ
ecj-12574	153	24	case	case	NOUN
ecj-12574	153	25	reports	report	VERB
ecj-12574	153	26	.	.	PUNCT
ecj-12574	154	1	seizure	seizure	VERB
ecj-12574	154	2	2021;91:117–31	2021;91:117–31	PROPN
ecj-12574	154	3	.	.	PUNCT
ecj-12574	155	1	case	case	NOUN
ecj-12574	155	2	report	report	NOUN
ecj-12574	155	3	[	[	X
ecj-12574	155	4	emergency	emergency	NOUN
ecj-12574	155	5	care	care	NOUN
ecj-12574	155	6	journal	journal	PROPN
ecj-12574	155	7	2024	2024	NUM
ecj-12574	155	8	;	;	PUNCT
ecj-12574	155	9	20:12574	20:12574	NUM
ecj-12574	155	10	]	]	X
ecj-12574	156	1	[	[	X
ecj-12574	156	2	page	page	NOUN
ecj-12574	156	3	69	69	NUM
ecj-12574	156	4	]	]	PUNCT
ecj-12574	156	5	non	non	ADJ
ecj-12574	156	6	-co	-co	PROPN
ecj-12574	156	7	mmerc	mmerc	PROPN
ecj-12574	156	8	ial	ial	PROPN
ecj-12574	156	9	us	us	PROPN
ecj-12574	156	10	e	e	NOUN
ecj-12574	156	11	o	o	NOUN
ecj-12574	156	12	nly	nly	ADV